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Chapter 1 
GENERAL INTRODUCTION 
 
Chronic Obstructive Pulmonary Disease 
Chronic obstructive pulmonary disease (COPD) is defined as a disorder that is 
characterized by airflow limitation that is not fully reversible. The airflow limitation is 
usually both progressive and associated with an abnormal inflammatory response of 
the lungs to noxious particles or gases.1 
The chronic airflow limitation is caused by a mixture of small airway disease 
(obstructive bronchiolitis) and parenchymal destruction (emphysema), the relative 
contributions of which vary from person to person. Chronic inflammation causes 
remodelling and narrowing of the small airways. Destruction of the lung parenchyma , 
also by inflammatory processes, leads to the loss of alveolar attachments to the 
small airways and decreases lung elastic recoil; in turn, these changes diminish the 
ability of the airways to remain open during expiration. The amount of airflow 
limitation is measured by spirometry. A simple classification, based on spirometric 
data is recommended by the Global Initiative for Chronic Obstructive Lung Disease: 
stage 0 to IV. (table 1)1 
 
COPD is a major and growing global health problem. It ranks the fourth place in most 
common causes of death world wide. It is the only common cause of death which 
prevalence has increased over the past twenty years, and maybe even more 
important, it will increase in both death-ranking and cause of chronic disability until 
2020. COPD primarily affects middle aged and older persons. Smoking is the most 
frequent cause of the development of COPD, accounting for more than 90% of cases 
in developed countries. However, COPD develops in only a minority of smokers (10 
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to 20 percent), indicating that there are differences in individual susceptibility to the 
effects of cigarette smoking.2 
 
Table 1: Classification of COPD by severity (GOLD guidelines)1 
stage characteristics 
0: at risk -normal spirometry 
-chronic cough and sputum production 
I: mild COPD -FEV1/FVC<70% 
-FEV1≥80% predicted 
-with or without chronic symptoms; cough, sputum production 
II:moderate COPD -FEV1/FVC<70% 
-50%≤ FEV1<80% predicted 
-progression of symptoms, with shortness of breath typically developing 
on exertion. 
III: severe COPD -FEV1/FVC<70% 
-30%≤ FEV1<50% predicted 
-increased shortness of breath, and repeated exacerbations which have 
an impact on Quality of Life 
IV: very severe 
COPD 
-FEV1/FVC<70% 
-FEV1<30% predicted or presence of chronic respiratory failure 
 
 
Respiratory complaints are variable and usually consist of cough, sputum production 
and recurrent exacerbations. These complaints usually progress with increasing 
disease severity. Most patients experience dyspnea on exertion, or even at rest when 
the disease progresses. COPD not only leads to respiratory problems, it also leads to 
systemic abnormalities. A lot of patients suffer from exercise intolerance. Maximal as 
well as endurance exercise capacity are often diminished. Furthermore, systemic 
inflammation can be found in COPD patients.3 Peripheral muscle weakness is often 
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present in COPD patients, which also contributes to exercise limitation.4-13  Weight 
loss and low fat free mass index is another important abnormality, which is 
associated with increased mortality and diminished exercise capacity.14;15 (see table 
1) 
 
Respiratory muscles 
The primary ventilatory muscle is the diaphragm. It is active throughout the entire life 
of an individual and to a certain extent represents the sole skeletal muscle that is 
essential for life. Other respiratory muscles are the scalenes and the external 
intercostals (inspiratory muscles) and abdominal muscles (rectus abdominis, external 
and internal obliques and transverses abdominis) and internal intercostals (expiratory 
muscles).16;17 Respiratory muscles improve their function in response to training, like 
all skeletal muscles. 
Dysfunction of the respiratory muscles frequently occurs in patients with COPD. 
Reduced respiratory muscle function is caused by either respiratory muscle 
weakness, relative inactivity due to dyspnea, increased work of breathing due to 
changes in the airways and lungs and inefficiency of the inspiratory muscles because 
of hyperinflation or a combination of these factors.18 Respiratory muscle weakness 
may occur because of metabolic abnormalities such as malnutrition, abnormalities in 
arterial blood gases and electrolyte concentrations, infection and chronic systemic 
steroid administration. Airway obstruction due to mucus and/or inflammation of the 
airways, and loss of alveolar tissue, which all contribute to dynamic airway 
compression and hyperinflation, lead to increased work of breathing. Hyperinflation, 
leading to abnormally large lung volumes, causes the inspiratory muscles to operate 
at lengths shorter than normal. Because of the length-tension curve, this condition 
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places these muscles at a disadvantage for tension generation. The diaphragm, 
under quiet breathing conditions performing about 70-80% of the work of breathing, 
is affected to the greatest degree.17 
 
This respiratory muscle dysfunction may contribute to sensations of dyspnea, limited 
exercise tolerance, reduced quality of life, and as the disease progresses, 
hypercapnic ventilatory failure.18;19 The clinical importance is ambiguous: first of all 
there is the patient with her or his complaints and disabilities. Secondly an increased 
utilization of health care resources was observed in COPD patients with weakness of 
the respiratory muscles.20 
As a consequence, treatment of respiratory muscle dysfunction has gained interest in 
the last three decades. Treatment modalities that were used include 
pharmacotherapy, nutritional repletion, and respiratory muscle training to improve 
strength and endurance. In this thesis we focus on respiratory muscle training. 
 
Training principles  
Training of the ventilatory muscles must follow the basic principles of training for any 
striated muscle with regard to the intensity and duration of the stimulus, the 
specificity of training and the reversibility of training. The basic principles are that for 
muscle fibres to change structure and function they must be stressed (loaded) above 
a critical threshold. This load may be applied by increasing the frequency of training, 
the duration of training, the intensity of the loading, or a combination of these factors. 
Secondly training is specific for the stimulus- that is, strength training will increase 
fibre size (muscle hypertrophy) whereas endurance training will increase oxidative 
enzymes and mitochondrial density, myoglobin content, and capillary density. 
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According to this principle, respiratory muscle training will improve respiratory muscle 
function during day to day activities when the type of recruitment pattern during 
training is most similar to the recruitment pattern required during those activities. 
Leith and Bradley showed that indeed ventilatory muscle strength or endurance can 
be specifically increased by appropriate ventilatory muscle training programs.21 
Furthermore training is reversible and the effects will be reduced (deconditioning) if 
the training ceases. As soon as the individual stops training, the structural and 
functional changes within the body related to training will begin to return to baseline. 
18;22-24 
Concerning the respiratory muscles in patients with COPD, strength training, as well 
as endurance training has been performed, with different rates of success. Training 
of the respiratory muscles can also be achieved by both specific and non-specific 
conditioning programs. The obvious non-specific program is total body exercise. 
Specific training programs include inspiratory resistive training and threshold loading 
(strength training) and normocapnic hyperpnea (endurance training).  
The effects of respiratory muscle training can be evaluated in several ways. First of 
all the performance of the muscles itself can be tested. Respiratory muscle strength 
can be tested by means of evaluation of maximal in- and expiratory pressures (Pimax 
and Pemax).25;26 Endurance capacity can be tested by incremental threshold 
loading27 and other endurance tests like maximal sustained ventilatory capacity. 
Determination of the tension-time index also provides information in this way.28 
Furthermore, the effects of respiratory muscle training can be evaluated in terms of 
functional and endurance exercise capacity, which are useful outcome 
measurements as was pointed out in a recent editorial by Polkey and Moxham.29 
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Respiratory muscle strength training: inspiratory resistive training and 
threshold loading 
Respiratory muscle strength training can be described as performing (sub-)maximal 
inspiratory or expiratory manoeuvres against a resistance. The repetition rate is low 
(5-10 repetitions/minute). The primary goal of strength training is to improve force 
production of the respiratory muscles, thereby also improving, to some extent the 
endurance capacity of these muscles, and eventually improving the exercise capacity 
of the patient and reducing dyspnea. 
 
Inspiratory resistive training (IRT) is a well known respiratory muscle strength- 
training technique, aimed at generating high inspiratory pressures. During IRT the 
patient inspires through a mouthpiece with a two-way valve with a resistance in the 
inspiratory line, usually at normal breathing frequencies. This method is highly 
dependent on the breathing strategy and subjects can adopt a non-fatiguing 
breathing pattern with low-flow rates.30 Essentially, this type of training follows Ohm’s 
law characteristics: P=VxR (P=driving pressure, V=inspiratory flow, R=resistance). 
When imposing only a resistance (R) the patient has two degrees of freedom to 
regulate breathing: pressure (P) and flow (V). Consequently, in this type of training, 
two parameters have to be imposed: P and R or V and R. Thus the breathing pattern 
is strictly defined and controlled.31 Expiration is unimpeded.  
 
Threshold loading is a method which imposes pressures independent of flow-rates. 
Subjects have to breathe through a device with an inspiratory valve (weighted 
plunger) or a spring loaded inspiratory valve. This inspiratory valve is opened when a 
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critical mouth pressure is reached.32 It can also be performed for expiratory muscle 
training. 
 
Most studies using these techniques showed that respiratory muscles can be trained. 
31;33-40 Some studies also showed a reduction of dyspnea.34-38 The effects of 
respiratory muscle strength training on general exercise capacity are however not 
unambiguous. Some investigators found a modestly increased exercise capacity 
after IRT33-37;39;41-43, whereas other studies did not reveal such effects.44;45 These 
differences may be due to the method and protocol of IRT that was used, due to 
patient selection, as well as the fact that the outcome parameters of these studies 
mostly were incremental maximal exercise tests.  
 
Normocapnic hyperpnea: Respiratory Muscle Endurance Training (RMET)  
Normocapnic hyperpnea is a mode of endurance training of the respiratory muscles. 
This Respiratory Muscle Endurance Training (RMET) has much wider potential 
clinical application than respiratory muscle strength training because the respiratory 
muscles must remain active continuously even when placed under added loads, for 
example during exercise, infection, or in case of severe COPD even during activities 
of daily life. Normocapnic hyperpnea is based on non-resistive hyperpnea, in which 
patients are inspiring or rebreathing CO2 in order to maintain CO2 homeostasis. 
RMET may be closer related to daily life situations of COPD patients. It has only 
been used for research purposes and not for routine clinical use, because of the 
complicated equipment needed, requiring a laboratory setting.19;46 
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Normocapnic hyperpnea requires the individual to sustain a period of hyperpnea for 
about 15 minutes. It is probably the best technique for improving endurance of the 
respiratory muscles at high speeds of muscle contraction, which occurs during 
hyperpnea and exercise.18 An improvement of 268% in breathing endurance was 
found after isolated normocapnic hyperpnea in healthy sedentary subjects, whereas, 
in the same study, a sub-maximal exercise test increased with 50%.47 Improvements 
in respiratory muscle function and exercise performance were described in trained 
athletes.48 COPD-patients trained with RMET showed improvement of respiratory 
muscle function49 and exercise performance.50-52  
 
Home-based normocapnic hyperpnea requires special equipment to maintain arterial 
blood gases within a physiological range, because during a period of hyperpnea the 
partial pressure of arterial carbon dioxide (paCO2) decreases. CO2-homeostasis 
during normocapnic hyperpnea can be achieved by adding an external dead space to 
the respiratory system. Because of a lack of a home training device for normocapnic 
hyperpnea, this kind of training method has rarely been used as a training mode for 
patients with COPD. RMET was applied as a home-based training regimen in only 
two studies in patients with COPD.51;52 The studies by Boutellier and Scherer,47;48;52 
that are mentioned above, were performed with a specially developed, electro-
mechanical device, which is expensive and complicated. Enlargement of the 
respiratory dead space can also be done by breathing through a tube, which is much 
easier and less expensive. Therefore Respiratory Muscle Endurance Training 
(RMET) by means of tube breathing, might be a promising technique enabling a 
widespread use. 
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Exercise capacity 
Maximal exercise tests are widely used to asses the factors that limit exercise 
tolerance, to quantify the extent of disability and to set up an exercise training 
program. 
 
Exercise tolerance can be limited in several ways. The respiratory and cardio-
circulatory systems are involved in the transport of oxygen from the atmosphere to 
the mitochondria of skeletal muscle.  
Respiratory function can be diminished by impaired ventilatory capacity, impaired 
diffusion and ventilation-perfusion mismatch. CO2 elimination is limited by alveolar 
ventilation, whereas O2 uptake is most vulnerable at the diffusion through the alveolar 
membrane.  
The cardio-circulatory transport of oxygen is dependent on cardiac output, peripheral 
vascularisation and the quantity of haemoglobin.  
Exercise tolerance can furthermore be diminished because of peripheral muscle 
weakness, neurological problems and psychological factors such as dyspnea. 
 
It is known that limited exercise capacity is frequently observed in patients with 
COPD. Diminished ventilatory efficiency and dyspnea can be one of the factors 
contributing to this impairment in exercise capacity. This diminished ventilatory 
efficiency results from either respiratory muscle weakness, increased work of 
breathing due to changes in the airways and lungs and inefficiency of the inspiratory 
muscles because of hyperinflation, or a combination of these factors.18  
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Patients with mild to moderate COPD (GOLD I and II) are, similarly to healthy 
subjects, limited during exercise by the cardio-circulatory system and on metabolic 
factors at the level of the peripheral muscles. During incremental exercise, these 
subjects may achieve their maximal, age-specific heart-rate and blood lactate may 
increase by more than 10 mmol/liter, reflected by a decrease in base-excess.53 
Dyspnea and perceived leg effort contribute to subjective exercise limitation.54 
 
Patients with severe COPD (GOLD III) are usually limited by their ventilatory system: 
either by abnormal respiratory mechanics or by gas exchange disturbances. Failure 
of the respiratory pump function leads to hypercapnia and eventually hypoxemia 
because of insufficient alveolar ventilation. Respiratory muscle function, amongst 
others, is an important determinant of exercise capacity.4 Maximal exercise capacity 
is substantially limited by dyspnea.55 At the point of maximal exercise, maximal 
minute ventilation approaches or exceeds maximal voluntary ventilation, which as a 
consequence, results in a low or negative breathing reserve. Furthermore, dynamic 
hyperinflation during exercise may lead to an increased load on the respiratory 
muscles and increased exercise intolerance.56 However, dyspnea may limit exercise 
before those mechanisms lead to a physiological limitation. As a consequence, age 
specific maximal heart rate will not be reached. Thus improvement of respiratory 
muscle function and improved alveolar ventilation, reduction of dyspnea, as well as 
bronchodilatation, may lead to improvement of exercise capacity.33;35-37;57 
 
Although it was generally accepted that ventilation does not limit exercise 
performance in normal subjects without airway obstruction, literature from sports 
medicine suggests that respiratory muscle endurance training by means of 
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normocapnic hyperpnea in healthy volunteers leads to a substantial improvement of 
breathing endurance and endurance exercise capacity.47;48;58 It is strikingly apparent 
that people with fully trained respiratory muscles have the lowest minute-ventilation 
possible, and their respiratory muscles fatigue later and metabolise more lactate, but 
the mechanism by which respiratory training improves overall physical performance 
is as yet unknown.59  
 
It also seems important to take the different outcome parameters into account. 
Studies performed before 1990 mostly used maximal incremental exercise tests to 
determine exercise capacity,41;42;45;60 whereas later studies also tested endurance 
capacity by means of constant load exercise testing.47;48;52;57;58;61-65 Constant load 
exercise testing (CLET) can be used to measure endurance exercise capacity and to 
compare ventilatory and metabolic parameters at the same work-rate before and 
after intervention. The latter being an effort independent measurement of training 
effects. CLET has been proven to be a reproducible, reliable and valid method to 
assess endurance exercise capacity in patients with COPD.66;67 
Considering the above-mentioned, training methods for respiratory muscles that 
improve endurance capacity may be more beneficial to patients with COPD, as in 
daily life maximal exercise is seldomly performed. Therefore outcome parameters 
should also focus on endurance capacity rather then maximal exercise. 
 
Dyspnea 
Dyspnea is an important symptom in patients with COPD. Dyspnea may be defined 
as the unpleasant awareness of the need to breathe. Dyspnea originates a.o. in the 
central nervous system because of an imbalance between motor neural output to the 
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respiratory muscles and the magnitude of ventilation resulting from it. In patients with 
COPD the sense of respiratory muscular effort is an important determinant of 
dyspnea.68;69 The clinical rating of dyspnea as measured by the Baseline Dyspnea 
Index is significantly correlated with maximal inspiratory and expiratory pressure.70 
Several studies have shown that respiratory muscle strength-training, by means of 
resistive breathing or threshold loading, leads to an improvement of respiratory 
muscle function31;33-39 and an improvement of dyspnea33;35-38 in patients with COPD. 
Only one study, using endurance respiratory muscle training in COPD patients, 
looked at the effects of this training regimen on dyspnea. Scherer and co-workers 
showed an improvement of dyspnea after RMET.52 
Other factors contributing to dyspnea are hypercapnia and hypoxia sensed by the 
chemo receptors. Proprio receptors in the respiratory muscles, especially the muscle 
spindles in the intercostals, are important contributors to dyspnea sensations. These 
spindles are essential in detecting a length-tension inappropriateness in every 
muscle. The tension/force, relative to the maximal force that a muscle can generate, 
is a major determinant of the sensation of load on a muscle. This type of sensations 
from intercostals muscles, is perceived as dyspnea. Furthermore different signals 
which originate in the parenchyma of the lung and in the airways contribute to 
dyspnea. It can be concluded that dyspnea is a multi-factorial problem. Interventions 
leading to improvement of respiratory muscle function or adaptation to signals from 
mechanoreceptors or chemo receptors thus may lead to a reduction of the 
unpleasant sensation of breathing/dyspnea.  
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Health related Quality of life 
Survival and physiological parameters of airway narrowing do not represent the full 
impact of the disease for patients with COPD. It is also important to reduce the 
personal and social burden of the disease by improving symptoms and functional 
status.71 Therefore health related quality of life has become an important outcome for 
treatment in studies with COPD patients. Measurement of health related quality of 
life, is a means of quantifying, in a standardised and objective manner, the impact of 
disease on a patient’s daily life, health and wellbeing.72 A number of instruments 
have been developed to measure (changes in) health status in COPD: The Chronic 
Respiratory Disease Questionnaire and the St George’s Hospital Questionnaire have 
been validated and have proven to be responsive to (training induced) changes.73;74 
Only one study looked at the effects of RMET on quality of life in COPD. An 
improvement of the physical, but not the mental component of the SF-12 health 
questionnaire was found.52 Since dyspnea is an important determinant of the health 
related quality of life in COPD it can be speculated that, once dyspnea improves as a 
result of respiratory muscle training, quality of life also may improve. 
 
Pulmonary rehabilitation 
Pulmonary rehabilitation is a multidisciplinary program of care for patients with 
chronic respiratory impairment that is individually tailored and designed to optimise 
physical and social performance and autonomy.75 The principal goals of pulmonary 
rehabilitation are to reduce symptoms, improve quality of life, and increase physical 
and emotional participation in everyday activities.1 To achieve these goals, smoking 
cessation must be encouraged and patients should be supported. Furthermore, 
medical therapy must be optimised and exercise training, physical therapy, breathing 
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retraining, nutrition counselling and education of the patient and family must be 
carried out.1;76-79 The diagnosis must of course be accurate and an evaluation of the 
exercise limitation is preferable. COPD patients at all stages of disease benefit from 
exercise training programs. Specific pulmonary rehabilitation programs are 
recommended for GOLD stage II to IV.1 There are no specific patient selection 
criteria, but patients must have symptomatic chronic lung disease. They must be 
stable with optimal standard medical therapy and experience functional limitation 
from their disease. Furthermore they must be motivated and there should be no 
interfering or unstable medical conditions.75 The benefits of pulmonary rehabilitation 
in patients with COPD have been well established: improvement of exercise capacity, 
reduction in perceived breathlessness, improvement of quality of life, reduction in the 
number of hospitalisations and a reduction in anxiety and depression associated with 
COPD.1;80-83 Guidelines for the assessment of candidates and goals of treatment 
have also been published in the Netherlands.84 
Respiratory muscle training in pulmonary rehabilitation is a controversial issue.76-79 
Selection of patients, different training modalities and protocols and measurement of 
different outcome parameters may be the cause of this. However, the recent GOLD 
guidelines mention that respiratory muscle training is beneficial, especially when 
combined with general exercise training.1  
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OUTLINES AND AIMS OF THE STUDY 
 
In the following studies we describe the applicability of home-based normocapnic 
hyperpnea by means of tube breathing and the effects of this respiratory muscle 
endurance training on CO2-homeostasis, endurance exercise capacity, dyspnea, 
quality of life and pulmonary rehabilitation. 
 
The aim of chapter 2 was to study the feasibility and safety of tube breathing as a 
new method of respiratory muscle endurance training (RMET) and its effects on CO2 
homeostasis in healthy volunteers. 
 
In chapter 3 we describe the effects of tube breathing, on CO2 homeostasis in COPD 
patients.  
 
Chapter 4 focuses on the results of home-based RMET, comparing normocapnic 
hyperpnea RMET with sham training, in patients with moderate to severe COPD, 
waiting for in-patient pulmonary rehabilitation. Outcome parameters were respiratory 
muscle performance, endurance and maximal exercise capacity and perception of 
dyspnea. 
 
In chapter 5, which is closely related to chapter 4, we describe the effects of home-
based RMET compared to sham training, with regard to quality of life and dyspnea in 
daily activities, in patients with moderate and severe COPD, before in-patient 
pulmonary rehabilitation. 
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The aim of chapter 6 was to study the effects of optimising the respiratory muscles by 
means of RMET, on the outcome of a pulmonary rehabilitation program. We 
hypothesized that optimising the respiratory muscles before the rehab program would 
lead to a better outcome of this program in terms of respiratory muscle performance 
and endurance exercise capacity. 
 
Chapter 7 gives a summary of the studies in this thesis. The general conclusions and 
implications for daily practice are discussed. 
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ABSTRACT 
Normocapnic hyperpnea has been established as a method of respiratory muscle 
endurance training. This technique has not been applied on a large scale because 
complicated and expensive equipment is needed to maintain CO2-homeostasis 
during hyperpnea. This CO2-homeostasis can be preserved during hyperpnea by 
enlarging the dead space of the ventilatory system. One of the possibilities to enlarge 
dead space is breathing through a tube. If tube-breathing is safe and feasible, it may 
be a new and inexpensive method for respiratory muscle endurance training, 
enabling its widespread use. 
The aim of this study was to evaluate the safety of tube-breathing and investigate the 
effect on CO2-homeostasis in healthy subjects.  
20 healthy volunteers performed 10 minutes of tube-breathing (dead space 60% of 
Vital Capacity). Oxygen-saturation, PaCO2, respiratory muscle function, hypercapnic 
ventilatory response and dyspnea (Borg-score) were measured. Tube-breathing did 
not lead to severe complaints, adverse events or oxygen desaturations. 14 out of 20 
subjects became hypercapnic (PaCO2 >6,0 kpa) during tube-breathing. There were 
no significant correlations between PaCO2 and respiratory muscle function or 
hypercapnic ventilatory responses. The normocapnic versus hypercapnic subjects 
showed no significant differences between decrease in oxygen saturation (–0,7% 
versus –0,2% respectively, p=0,6), Borg score (4,3 versus 4,7, p=0,9) , respiratory 
muscle function nor hypercapnic ventilatory responses.  
Our results show that tube-breathing is well tolerated amongst healthy subjects. No 
complaints, nor desaturations occurred. Hypercapnia developed in a substantial 
number of subjects. When tube-breathing will be applied as respiratory muscle 
training modality, this potential development of hypercapnia must be considered. 
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 INTRODUCTION 
The function of respiratory muscles can improve in response to training. 
Normocapnic hyperpnea is probably the best technique for improving endurance 
respiratory muscle function, which is required during exercise.1 During normocapnic 
hyperpnea the subject has to sustain a period of hyperpnea for about 10 to 15 
minutes. Respiratory Muscle Endurance Training (RMET) is based on the principle of 
normocapnic hyperpnea. RMET, performed with a specially designed, expensive 
electromechanical device showed an improvement of 268% in breathing endurance 
in healthy sedentary subjects, and more-over, the endurance time of a sub-maximal 
exercise test increased with 50% in this study without placebo-training group.2 RMET 
also led to improvements in respiratory muscle function and exercise performance in 
a study in trained athletes, also without a placebo group and in a randomised 
controlled trial in patients with Chronic Obstructive Pulmonary Disease (COPD).3,4
Despite these promising results, RMET is not applied on a large scale because of 
this complicated and expensive equipment that is needed to maintain O2 and CO2-
homeostasis during hyperpnea. This CO2-homeostasis can also be preserved during 
a period of hyperpnea by enlarging the dead space of the ventilatory system. One of 
the possibilities to do so is to breathe through a tube. Thus, RMET by means of tube-
breathing might be a new, inexpensive method to perform respiratory muscle 
training, possibly even in a home-based setting. However, the safety and the effects 
of this kind of tube-breathing on CO2-homeostasis have never been evaluated. 
Therefore we investigated whether tube-breathing might be a safe and inexpensive 
technique to perform RMET, enabling widespread use. 
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The aim of this study was to study the safety and feasibility of tube-breathing in 
healthy subjects. We therefore evaluated oxygenation, perception of dyspnea and 
CO2-homeostasis in 20 healthy volunteers during tube-breathing.  
 
SUBJECTS AND METHODS 
The study population consisted of twenty healthy subjects (13 females) (table 1). 
Exclusion criteria were: a pulmonary medical history, pulmonary complaints and 
current smoking. Subjects were recruited by means of an advertisement in a free 
local paper. The subjects were informed about the purpose of this study and gave 
informed consent. The study was approved by the Ethics Committee of the University 
Hospital Nijmegen. 
  
Pulmonary function test 
Pulmonary function tests at rest were measured according to ERS-criteria 5 with a 
Sensorloop spirometer (Sensormedics corporation, Bilthoven, the Netherlands): 
forced vital capacity (FVC) and forced expiratory volume in 1 second (FEV1) were 
recorded.  
 
Hypercapnic ventilatory response 
The steady state ventilatory response to CO2 was measured. Subjects breathed in a 
closed spirometer circuit (Godart, Bilthoven, the Netherlands) in which the soda lime 
absorber could be partially bypassed with a three way valve. Oxygen was 
supplemented. End-tidal PCO2 was monitored at the mouth (Drager, Typ 8290000). 
After at least 5 minutes, when the end-tidal PCO2 value was stabilized, the soda lime 
absorber was partially bypassed. When the end-tidal PCO2 increased by 1 kPa the 
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bypass around the soda lime absorber was readjusted to prevent the end-tidal PCO2 
from rising any further. After 5 minutes in this steady state the test was ended. Tidal 
volume and breathing frequency were obtained from the spirometer and were 
converted to minute volume of ventilation (VE). The ventilatory response (S) to 
carbon dioxide is the slope of the relationship of ventilation versus end-tidal PCO2 
(l/min/kpa).6,7
 
PImax/PEmax
Maximal static inspiratory and expiratory mouth pressures (PImax and PEmax) were 
measured using a flanged mouthpiece connected to a rigid, plastic tube with a small 
air leak. Pressure was measured with a pressure transducer (Validyne, Northridge, 
California, USA) and recorded (Kipp & Zonen, Delft, the Netherlands). Plateau levels 
for PImax were measured from residual volume, for PEmax from total lung capacity.8 
 
Threshold loading 
Inspiratory threshold loading was used to measure inspiratory muscle endurance. 
Subjects, wearing a nose clip, were connected with a mouthpiece to a threshold 
loading device.9 They inspired against a loaded valve, starting with a load equal to 
10% of Pimax, and 25 gram weights were added at 1.5 minute intervals.10 Pressure 
was measured inside the mouthpiece with a pressure transducer (Validyne, 
Northridge, California, USA). Breathing was continued until inspiration could no 
longer be sustained. The pressure achieved during the heaviest load tolerated for at 
least 45 seconds was defined as the maximal sustainable inspiratory pressure 
(SIPmax).  
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Table 1.   Variables for normocapnic versus hypercapnic group. 
Variable Normocapnic 
Mean (SD) 
Hypercapnic 
Mean (SD) 
P-value 
(between groups) 
Female/male 4/2 9/5  
Age (yr) 21 (2) 29 (13) 0.9 
Height (cm) 176 (15) 177 (11) 0.7 
Weight (kg) 73 (13) 74 (12) 0.3 
FEV1 (litres) 4.0 (1.1) 3.9 (0.6) 0.9 
FEV1 (% predicted) 100 (12) 103 (10) 0.9 
FVC (litres) 4.6 (1.4) 4.4 (0.6) 0.7 
FVC (%predicted) 97 (10) 97 (14) 0.9 
PaCO2 rest (kPa) 5.1 (0.3) 
(38mmHg) 
5.3 (0.4)  
(40 mm Hg) 
0.9 
TBPaCO2 (kPa) 5.2 (0.7)  
(39 mm Hg) 
6.6 (0.4)  
(50 mm Hg) 
0.01 
 Delta PaCO2 (tube-rest 
(kPa)) 
0.09 (0.60)  
(1 mm Hg) 
1.29 (0.50)  
(10 mm Hg) 
0.01 
SaO2 rest 98.5 (0.5) 96.2 (2.0) 0.02 
SaO2 tube 97.8 (2.0) 95.9 (1.0) 0.02 
Delta SaO2 (tube-rest (%)) -0.7 (1.9) -0.2 (1.9) 0.6 
Heart beats/min rest 74 (6) 70 (11) 0.5 
Heart beats/min tube 81 (10) 81 (12) 0.7 
Borg 4.3 (2.9) 4.7 (1.9) 0.9 
S (l/min/kPa) 6.7 (4.7) 10.8 (7.2) 0.7 
SIPmax (kPa) 3.6 (1.6) 4.5 (1.9) 0.2 
PImax (kPa) 7.1 (2.7) 8.7 (2.4) 0.2 
PImax % pred 82 (32) 99 (28) 0.3 
PEmax (kPa) 9.8 (3.9) 10.1 (3.1) 0.7 
PEmax % pred 86.5 (29.1) 88.1 (26.3) 1.0 
Data reported as mean (standard deviation)  
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Legend to Table 1.  
FEV1 = forced expiratory volume in litres in 1 sec  
FVC = forced vital capacity in litres 
PaCO2 = capillary blood pressure of carbon dioxide 
PaCO2 rest = PaCO2 at rest/before tube breathing  
TBPaCO2 = PaCO2 at the end of 10 minutes tube breathing  
Delta PaCO2 tube-rest = difference between PaCO2 value during tube breathing and resting 
value  
SaO2 rest = oxygen saturation at rest 
SaO2 tube = oxygen saturation at the end of 10 minutes tube breathing 
Delta SaO2 tube-rest = difference between SaO2 value during tube breathing and resting 
value 
Borg = Borg-score at the end of tube breathing 
S = slope of ventilatory response to CO2  
SIPmax = maximal sustainable inspiratory pressure in kilopascal 
PImax = maximal inspiratory pressure in kilopascal 
PImax % pred = maximal inspiratory pressure as percentage from reference value 
PEmax = maximal expiratory pressure in kilopascal 
PEmax % pred = maximal expiratory pressure as percentage from reference value 
  
 
External dead space ventilation (tube-breathing) 
The external dead space consisted of a wired bore spirometer-tube (internal diameter 
3 cm, preliminary measured resistance of one meter of tube: 0.03 kPa/l/sec), 
connected to a mouthpiece. The length of the tube, representing the dead space, 
was adjusted to 60% of the forced vital capacity (FVC) 2, because during exercise, 
when minute ventilation rises, tidal volume increases to about 60% of the vital 
capacity and remains constant thereafter.11 A capnograph (Drager, Type 8290000) 
was connected to the mouthpiece, to monitor the end-tidal PCO2. The sampled gas 
was returned from the capnograph to the mouthpiece. The subjects breathed through 
the tube during 10 minutes, at an imposed frequency of 15 breaths/min, and at an 
inspiratory versus expiratory-time ratio of 1:2, using a metronome (Qwik Time QT5, 
quartz metronome). Before the experiment subjects were instructed to take deep 
breaths, to overcome the large dead space. They were seated and rested during 3 
minutes. 30 seconds before the start of tube breathing (PaCO2 rest) and 30 seconds 
before ending tube-breathing (TBPaCO2), an arterialized capillary blood-gas sample 
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was taken from a warmed fingertip. Arterial oxygen saturation and heart rate were 
measured noninvasively by oximetry (Nonin Medical Inc. USA model 8500 MA). 
Perception of dyspnea at the end of tube-breathing was measured with a modified 
Borg-scale (BORG).12 
 
Protocol 
After the pulmonary function test, the hypercapnic ventilatory response was 
determined, followed by measurement of Pimax and Pemax. Next threshold loading 
was performed. The 3 hour session ended with tube-breathing. All experiments were 
performed in the late morning and early afternoon. 
Subjects were resting for 20 minutes between each test. 
 
Statistics 
Pearson correlations between different parameters were determined. Furthermore, 
subjects were divided into two groups: normocapnic versus hypercapnic, which was 
dependent on their TBPaCO2. A PaCO2 ≤ 6.0 kPa was defined as normocapnia. 
Mean values between groups were compared. Data are reported as mean ± SD. The 
Mann-Whitney U test was used to test significant differences between the two 
groups. Significance was set at p<0.05. Statistics were performed using SPSS. 
 
RESULTS 
Table 1 shows the characteristics and the results of the subjects.  
Tube volumes ranged from 2.0 to 4.4 litres (=60% of FVC). During tube-breathing, 14 
out of 20 subjects became hypercapnic (TBPaCO2 > 6 kpa). Besides of dyspnea, 
there were neither severe complaints, nor adverse events. There were no significant 
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correlations between PaCO2 and the ventilatory response to CO2, PImax , PEmax or 
SIPmax. Subsequently the subjects were divided into two groups to compare mean 
values: normocapnic versus hypercapnic at the end of tube-breathing. In the 
normocapnic group PaCO2 remained constant: 5.1 (0.3) kPa [mean (± SD)] at rest, 
versus 5.2 (0.7) kPa at the end of 10 minutes tube-breathing (range during tube-
breathing 4.2-6.0 kpa). In the hypercapnic group PaCO2 showed a rise from 5.3 (0.4) 
kpa at rest, to 6.6 (0.4) kpa, p=0.001 (range during tube-breathing 6.1-7.7 kpa). A 
significant difference was found for oxygen saturation at rest as well as at the end of 
tube-breathing, p=0.02 (table 1). However, the change in oxygen saturation (tube-
breathing value minus resting value) did not differ significantly between the groups: 
normocapnic group –0.7% versus hypercapnic group -0.2%, p=0.6. Clinically relevant 
desaturations did not occur in neither group. Lowest saturation in both groups was 
94%.  
 
No significant differences in heart rate at rest, heart rate during tube-breathing, or 
perception of dyspnea (BORG) were recorded among the normocapnic and 
hypercapnic groups. Subjects had no complaints during tube-breathing, besides of 
dyspnea. 
 
Normocapnic and hypercapnic subjects showed no significant differences in the 
following characteristics: age, height, weight, FEV1, FVC, PaCO2 rest.  
 
The ventilatory response to CO2 (S) was not significantly different for the 
normocapnic (6.7 l/min/kPa (4.7)) versus the hypercapnic group (10.8 l/min/kPa 
(7.2)), p=0.2.  
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The normocapnic and hypercapnic subjects did not differ significantly in maximal 
inspiratory pressure (PImax) and maximal expiratory pressure (PEmax). Pimax was 
within a normal range in both groups: normocapnic: 82% (32%) predicted, versus 
hypercapnic 99% (28%) predicted, p=0,3.8 
  
Inspiratory muscle endurance measured with incremental threshold loading, showed 
no significant differences between the normocapnic and hypercapnic subjects: SIPmax 
3.6 (1.6) kpa versus 4.5 (1.9) kpa respectively, p=0.2.  
 
DISCUSSION 
The present study shows that tube-breathing in healthy volunteers is well tolerated. 
No clinically significant desaturations, severe complaints or adverse events occurred. 
It leads to hypercapnia in several subjects. Thus tube-breathing might be a feasible 
and inexpensive method to perform RMET, which suggests that it could become 
available to a large population. However, the potential development of hypercapnia 
must be considered when tube-breathing will be applied as endurance training for the 
respiratory muscles. 
 
To our knowledge this is the first study, evaluating tube-breathing as a new method 
for RMET. Therefore we investigated the safety of this method, first of all in healthy 
subjects. Tube-breathing in our study did not lead to severe complaints, adverse 
events or relevant oxygen desaturations. A heart rate of 81 beats/minute at the end 
of 10 minutes tube-breathing does not reflect severe stress. Perception of dyspnea 
(Borg-score) was moderate to severe at the end of the tube-breathing session.  
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We also looked at the effects of tube-breathing on CO2-homeostasis. Strikingly, 
ventilation was not adapted to maintain a normal PaCO2 during tube-breathing in all 
healthy subjects and consequently alveolar hypoventilation occurred. One of the 
limitations of this study is the fact that we did not measure tidal volumes and minute 
ventilation during tube breathing in our subjects. Thus, the question remains whether 
tidal volumes or probably the fixed respiratory rate (15 breaths/minute), or a 
combination of these two variables, were the limiting factors in achieving an 
adequate alveolar ventilation. On the other hand, the net effect of the alveolar 
ventilation was measured on end-tidal PCO2. This partly obviates the necessity to 
measure minute ventilation as such. However, as a consequence, hypercapnia 
developed in this subset of subjects. Brief increases in PaCO2 (lasting several 
minutes) produce a sensation of respiratory discomfort (air hunger), which is neither 
a harmful, nor a dangerous situation. Hypercapnia also leads to cerebral 
vasodilatation and it diminishes in- and expiratory upper airway resistance.13,14 In 
several studies (in healthy subjects) the effect of induced acute hypercapnia on 
ventilation was evaluated.15-17 However, the design of these studies was different 
from ours because, spontaneous breathing was compared to mechanical ventilation. 
It was shown that ventilation at the same level of hypercapnia, increased even more 
during spontaneous breathing, compared to mechanical ventilation. Furthermore, air 
hunger was much lower at the same level of hypercapnia during spontaneous 
breathing compared to mechanical ventilation. Mean levels of PaCO2 ranged from 
6,1 to 6,9 kpa. Thus it can be speculated that a small rise in PaCO2 during tube-
breathing might even lead to a more intense training stimulus. Moreover, even 
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prolonged exposure (5 days) to elevated levels of CO2 in healthy subjects, did not 
alter the ventilatory chemosensitivity to subsequent acute hypercapnia.18  
 
However, chronic hypercapnia due to respiratory muscle failure is an important 
complication and a poor prognostic marker, especially in patients with COPD.19 On 
the other hand, especially these patients are eligible for respiratory muscle training to 
attempt to prevent or postpone this respiratory muscle failure, which is, among other 
things, caused by impaired respiratory muscle function.20 Nevertheless, before 
applying RMET by means of tube breathing to patients with COPD, the safety, 
applicability and the appropriate training scheme of this technique have to be 
investigated in these patients. 
In Jederlinic’s classical study on resistance stress-testing and training of respiratory 
muscles in COPD-patients, these authors found that all patients hypoventilated, and 
desaturated.21 However, some of their patients were already hypoxemic at the start 
of the test (SaO2 84%). When performing this resistive stress test, Jederlinic’s 
patients hypoventilated. The ‘wisdom of their bodies’ had to make a choice between 
very strong exertion of their respiratory muscles versus accepting some degree of 
hypercapnia. Apparently they chose the latter. The subjects in our study, and also 
possibly future patients, face similar choices. As the resistive load in our study was 
distinctly lower than in Jederlinic’s study, one might expect that the urge/need to 
trade off a heavy respiratory load for some degree of hypercapnia, might be less.  
 
Dead space breathing or tube breathing has been studied in the past, however these 
studies are not comparable to our study design because our subjects were instructed 
to take deep breaths to overcome the large dead space (respiratory muscle 
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endurance training modality), whereas in the other tube-breathing studies the 
investigators looked at the spontaneous (physiological) effects of tube-breathing on 
ventilation.22-25
 
In determining the safety of tube-breathing we looked, among other things, at oxygen 
saturation. The upper part of the oxygen saturation curve levels off, which means that 
the partial pressure of O2 might fall while the oxygen saturation is still normal. 
However, the lowest saturation measured was 94%, which is not associated with 
(relevant) hypoxemia. This observation, along with dyspnea scores and heart rate 
during tube-breathing, underlines that tube-breathing is a safe method. 
 
The striking observation that hypercapnia developed in a large number of subjects 
could be explained by several mechanisms, which will be discussed below. 
A difference in the sensitivity of the chemo receptors to a certain change in PaCO2 
might be responsible for the development of hypercapnia during tube-breathing. This 
response to CO2 is mediated centrally by brainstem chemo receptors in the medulla 
and peripherally by the carotid and aortic bodies. A wide range of ventilatory 
responses to CO2 has been reported in the literature.26 Our subjects also showed a 
wide variance and the results of the hypercapnic ventilatory response could not 
explain the difference in TBPaCO2 between the two groups.  
 
Inspiratory muscle fatigue may lead to acute hypercapnic respiratory failure. One 
study investigated the effect of diaphragmatic fatigue on control of respiratory 
muscles and ventilation during CO2 rebreathing in healthy volunteers. It was 
concluded that diaphragmatic fatigue induces proportionally greater contributions of 
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inspiratory rib cage muscles, resulting in the preservation of ventilatory response to 
CO2, despite impaired diaphragmatic contractility.27 Diaphragmatic fatigue measured 
by cervical magnetic stimulation occurs following voluntary hyperpnea (until task 
failure), and lasts for at least one hour after hyperpnea.28 The subjects in this study 
breathed at 60% MVV during 517±58 seconds with a respiratory rate of 89±5 
breaths/min. Our subjects were healthy volunteers, breathing with a respiratory rate 
of 15 breaths/minute. Furthermore Pimax was within a normal range in both groups. 
Therefore respiratory muscle fatigue or weakness can not explain the difference in 
TBPaCO2 between both groups.  
 
There was a wider range of ages and there were more females in the hypercapnic 
group. It is difficult to establish whether this might have played a role in becoming 
hypercapnic. Despite this, they were all healthy subjects of whom it is difficult to 
estimate retrospectively whether these factors may have played a role in becoming 
hypercapnic. This would require another study. Furthermore, the sample size in our 
study could have contributed to the absence of statistically significant differences 
between the different parameters. 
 
Based on the knowledge that tube-breathing leads to a stimulation of ventilation 
because it increases the amplitude and leads to a change in the timing of the 
respiratory oscillations in arterial PCO2, we would have expected our subjects to 
remain at least normocapnic, and possibly somewhat hypocapnic.23-25 However, 
several subjects became hypercapnic. Neither respiratory muscle endurance, nor 
chemoreceptor sensitivity was significantly different between the groups, although 
the wide range in ventilatory responses to CO2 makes it hard to detect significant 
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differences. Especially when taken into account the small number of subjects that 
were studied, and therefore a type II error cannot be excluded. Despite these 
statistical remarks, these subjects “accepted” a higher PaCO2 value, rather than 
increase their minute ventilation and thus their work of breathing, in spite of the fact 
that there still was a breathing reserve. The perception of the work of breathing at the 
end of tube-breathing was the same in both groups as shown by the Borg scores. 
Similar differences can be observed in patients with severe COPD. Some maintain a 
high ventilation in order to remain normocapnic (so called “pink puffers”), and others 
do not seem to be bothered by the hypercapnia (so called “blue bloaters”). This fits 
with the recently proposed theory of natural wisdom, that protects these patients from 
the detrimental consequences of their disease, but with the inevitable cost of 
hypercapnia.29 It is, of course, extremely speculative to suggest that possibly these 
types of reactions may already be present in early life, before COPD ever develops. 
However, it is a known fact that there are great interindividual differences in 
ventilatory sensitivity to CO2 and there are several reports suggesting that heredity 
plays a very important role.25 Thus genetic set differences might determine the 
tendency to normocapnia or hypercapnia during tube-breathing. 
 
The observation that tube-breathing is well tolerated in healthy subjects, might have 
important implications for the applicability of this training technique. Nevertheless, 
further studies are necessary before application of RMET by means of tube-breathing 
can be recommended as safe in healthy subjects and these findings need to be 
confirmed in patients with COPD. The equipment for tube-breathing is inexpensive 
and almost everywhere available. This means that RMET by means of tube-
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breathing can be applied on a larger scale: in clinical research, and eventually in 
routine clinical use.  
 
In summary, the results of this experiment show that tube-breathing is well tolerated 
in healthy subjects. It does not lead to complaints, adverse events or desaturations. It 
results in hypercapnia in a substantial number of subjects. This response could not 
be related to any characteristics of the subjects. When tube-breathing will be applied 
as a respiratory muscle training modality, this potential development of hypercapnia 
must be considered. Furthermore, the appropriate training scheme in healthy 
subjects and the safety and applicability of tube-breathing in patients with COPD 
needs further investigations.  
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ABSTRACT 
The function of respiratory muscles can improve in response to training. Home-based 
endurance respiratory muscle training by means of tube-breathing is possibly a new 
training modality for respiratory muscles. The aim of this study was to investigate the 
effect of this tube-breathing on CO2 homeostasis in patients with chronic obstructive 
pulmonary disease (COPD). We hypothesized that the ventilatory control system will 
stimulate ventilation during tube breathing, in order to preserve normocapnia. 
Fourteen consecutive patients with moderate and severe COPD were included in the 
study. Pulmonary function test, hypercapnic ventilatory responses, endurance 
capacity of the respiratory muscles and tube-breathing with dyspnea scores (Borg) 
were performed.  
Strikingly, four patients became hypercapnic (PaCO2>6,0 kpa) during tube-breathing. 
These hypercapnic patients had significantly more severe COPD, more 
hyperinflation, a worse capacity of their respiratory muscles and more dyspnea 
during tube-breathing compared to the normocapnic patients. No significant 
difference was found for the hypercapnic ventilatory response. 
This study shows that tube breathing may lead to hypercapnia and more dyspnea in 
severe COPD patients, especially in those with impaired respiratory muscle capacity. 
The ventilatory controlling system does not seem to play an important role in this 
situation. 
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INTRODUCTION 
Impaired respiratory muscle function, due to respiratory muscle fatigue and 
weakness, leads to dyspnea and exercise intolerance in patients with chronic 
obstructive pulmonary disease (COPD).1 
 
The function of respiratory muscles can improve in response to training. This 
improved function, in turn, can potentially decrease dyspnea, improve exercise 
capacity and increase the ability to perform daily activities in patients with COPD.2-7 
Different training protocols have been designed for improving respiratory muscle 
strength in COPD patients, including targeted inspiratory resistance training and 
threshold loading. Both techniques lead to an improvement of respiratory muscle 
strength, but the effect on exercise performance is less unambiguous.6-11 However, 
the main function of the ventilatory muscles is to continuously perform low intensity 
contractions about 10 to 20 times per minute at rest. During exercise this frequency 
rises even up to 60 times per minute. Therefore specific endurance training may be 
much more effective. Respiratory Muscle Endurance Training (RMET) by means of 
normocapnic hyperpnea requires the individual to maintain a period of hyperpnea for 
about 15 minutes. This is probably the best technique for improving the endurance 
capacity of the respiratory muscles.2 The only study that performed home-based 
RMET in COPD patients, indeed showed improvement in respiratory muscle function 
and exercise capacity.12 However, the equipment needed to maintain a normocapnic 
situation during RMET is expensive and complicated. Therefore RMET, which is a 
technique with good prospects, is not applied on a large scale. 
 During hyperpnea, CO2-homeostasis can be achieved by enlarging the dead space 
of the ventilatory system, which can be done by breathing through a tube. Thus tube-
 49
Chapter 3 
breathing might be a simple and inexpensive way to perform RMET in a home based 
setting, enabling a widespread use of this promising training-method. However the 
effects of tube breathing on CO2-homeostasis in patients with COPD have never 
been evaluated. 
Therefore we investigated the effects of tube breathing on CO2-homeostasis in 
patients with COPD. We hypothesized that the ventilatory control system will regulate 
ventilation during tube breathing at such a level that normocapnia will be maintained. 
 
SUBJECTS AND METHODS 
Fourteen consecutive patients (3 female and 11 male) with moderate and severe 
COPD, (FEV1/FVC<70% and FEV1 post-bronchodilatation between 80% and 30% 
predicted) from the out-patient clinic,13 who were in a stable clinical condition for at 
least 6 weeks, participated in this study. Patients were excluded in case of recent 
exacerbation, hypoxemia or hypercapnia at rest, use of oral steroids and a medical 
history with thoracotomy. The subjects were informed about the purpose of this study 
and gave informed consent. The study was approved by the Ethics Committee of the 
University Hospital Nijmegen.  
 
Pulmonary function test 
Pulmonary function tests at rest were measured according to European Respiratory 
Society.14 The characteristics of the pulmonary function tests are listed in table 1.  
 
Hypercapnic ventilatory response 
The steady state ventilatory response to CO2 was measured. Subjects breathed in a 
closed spirometer circuit (Godant, Bilthoven, the Netherlands) in which the soda lime 
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absorber could be partially bypassed with a three way valve. Oxygen was 
supplemented. End-tidal PCO2 was monitored (capnograph Drager, Typ 8290000). 
After at least 5 minutes, when the end-tidal PCO2 value was stabilized, the soda lime 
absorber was partially bypassed. When the end-tidal PCO2 increased by 1 kPa the 
bypass around the soda lime absorber was readjusted to prevent the end-tidal PCO2 
from rising further. After 5 minutes in this steady state, the test was ended. Tidal 
volume and breathing frequency were obtained from the spirometer and were 
converted to minute volume of ventilation (VE). The ventilatory response (S) to 
carbon dioxide is the slope of the relationship of ventilation versus end-tidal PCO2 
(l/min/kPa).15;16 
 
PImax/PEmax
Maximal static inspiratory and expiratory mouth pressures (PImax and PEmax) were 
measured using a flanged mouthpiece connected to a closed, rigid, plastic tube with 
a small air leak. The pressure inside the tube was measured with a pressure 
transducer (Validyne, Northridge, California, USA) and recorded on a chart recorder 
(Kipp & Zonen, Delft, the Netherlands). Plateau-levels were taken for analysis. PEmax 
was measured from total lung capacity (TLC), PImax from residual volume (RV).17  
 
Incremental Threshold loading 
Incremental inspiratory threshold loading was used to measure respiratory muscle 
endurance. 
Subjects, wearing a noseclip, were connected with a mouthpiece to a threshold 
loading device described by Nickerson and colleagues.18 They inspired against a 
loaded inspiratory valve. Thus, a certain level of inspiratory pressure has to be 
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generated in order to overcome the threshold load and to initiate airflow. Pressure 
(Pth) was measured inside the mouthpiece with a pressure transducer(Validyne, 
Northridge, California, USA). Pth could be varied by adding weights to the plunger. 
The subjects started with a load equal to 10% of Pimax and 25 gram weights were 
added at 1.5 minute intervals.19 Breathing was continued until inspiration could no 
longer be sustained. The pressure achieved during the heaviest load tolerated for at 
least 45 seconds was defined as the maximal sustainable inspiratory pressure 
(SIPmax).  
 
External Dead space ventilation (tube breathing) 
The external dead space consisted of a tube (internal diameter 3 cm) connected to a 
mouthpiece. A sampling capnograph (Drager, Typ 8290000) was connected to the 
mouthpiece, to monitor the end-tidal PCO2. The sampled gas was returned from the 
capnograph to the mouthpiece. The external dead space was adjusted to 45% of the 
inspiratory vital capacity (IVC) of each individual patient. The subjects breathed 
trough the tube at an imposed frequency of 15/min and a Ti/Ttot ratio of 0.33, using a 
metronome (Qwik Time QT5, quartz metronome). Before the experiment, patients 
were instructed to take deep breaths, to overcome the large dead space. At the 
beginning and at the end of the tube breathing session an arterialized capillary blood-
gas sample was taken from a warmed fingertip (PaCO2-rest and TBPaCO2-45% 
respectively) . Arterial oxygen saturation and heart rate were measured noninvasively 
by oximetry (Nonin Medical Inc. USA model 8500 MA) during tube breathing. 
Dyspnea during tube breathing was measured with a Borg-scale at regular 
intervals.20 
 
 52 
Tube-breathing in COPD 
Protocol 
After pulmonary function testing, the hypercapnic ventilatory response was done, 
followed by measurement of Pimax and Pemax. Next incremental threshold loading 
was performed. The 3 hour session ended with tube breathing (45% IVC). All 
experiments were performed in the late morning and early afternoon. 
Subjects were resting for 20 minutes between each test. 
 
A PaCO2>6.0 kPa was defined as hypercapnia. 
 
Statistics 
Correlations between the different parameters were determined. Furthermore, 
patients were divided into two groups: normocapnic versus hypercapnic, depending 
on their TBPaCO2. Mean values ± SD were compared between the groups, by 
means of the Mann-Whitney U test. A value of p≤0.05 was considered statistically 
significant. Statistics were performed using SPSS 10.0 for Windows. 
 
RESULTS 
Table 1 shows the characteristics of the patients. 10 subjects remained normocapnic 
during tube breathing, whereas 4 subjects became hypercapnic. The correlation 
coefficients between TBPaCO2 and the other parameters were determined and 
subsequently the subjects were divided into two groups, normocapnic versus 
hypercapnic group and mean values were compared. 
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Table 1.  Variables for normocapnic versus hypercapnic group. 
Variable Normocapnic 
Mean (SD) 
Hypercapnic 
Mean (SD) 
P-value 
(between groups) 
Female/male* 2/8 1/3 ---------- 
Age (yr) 62 (8) 68 (9) 0.35 
Height (cm) 177 (10) 173 (12) 0.52 
Weight (kg) 79 (10) 64 (20) 0.22 
FFMI 17.3 (1.2) 16.1 (3.2) 0.50 
Packyears 20 (17) 38 (16) 0.11 
FEV1 (l) 2.0 (0.4) 1.0 (0.5) 0.02 
FEV1(%pred) 62 (12) 38 (16) 0.05 
FVC (l) 4.4 (0.9) 3.2 (0.7) 0.02 
FEV1/FVC 48 (12) 36 (11) 0.13 
FRC(%pred) 106 (22) 143 (18) 0.02 
Kco (%pred) 80 (25) 53 (18) 0.07 
S (l/min/kPa) 8.2 (6.4) 6.7 (4.9) 0.65 
PImax (kPa) 9.5 (1.9) 7.5 (1.5) 0.07 
PImax (%pred) 126 (25) 109 (27) 0.31 
PEmax (kPa) 9.7 (3.9) 8.9 (3.1) 0.82 
PEmax (%pred) 83 (21) 78 (47) 0.85 
SIPmax (kPa) 2.4 (1.6) 1.5 (1.9) 0.04 
PaCO2rest (kPa) 4.9 (0.3) 5.3 (1.2) 0.48 
PaCO2 45% (kPa) 5.2 (0.6) 6.7 (1.0) ---- 
Oxygen saturation 95 (5) 92 (3) 0.22 
Borg 6 (2) 9 (1) 0.007 
 
Legend to table 1: 
FFMI = fat free mass index 
Packyears = number of years, smoking 20 cigarettes a day 
FEV1 (l) = forced expiratory volume in litres in 1 second 
FEV1 (%pred) = forced expiratory volume as percentage predicted 
FVC (l) = forced vital capacity in litres 
FRC (%pred) = functional residual capacity as percentage predicted 
Kco(%pred) = transfer factor for carbon-monoxide/litre alveolar volume as percentage 
predicted 
 S = hypercapnic ventilatory response in litre per minute per kilopascal  
PImax = maximal inspiratory mouth pressure in kilopascal 
PImax(%pred) = maximal inspiratory mouth pressure as percentage predicted 
PEmax = maximal expiratory mouth pressure in kilopascal 
PEmax(%pred) = maximal expiratory mouth pressure as percentage predicted 
SIPmax = maximal sustainable inspiratory pressure in kilopascal 
PaCO2 = pressure of carbon dioxide in arterialized capillary blood in kilopascal 
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PaCO2rest = PaCO2 at rest/before tube breathing  
PaCO2 45% = PaCO2 at the end of tube breathing 
Oxygen saturation = oxygen saturation at the end of tube breathing 
Borg = Borg-score at the end of tube breathing 
 
 
Correlations 
The correlation coefficient for FEV1 as percentage from predicted and TBPaCO2 was 
–0.30, p=0.4. FEV1/FVC showed no significant correlation with PaCO2.  
Functional residual capacity as percentage of predicted normal value (FRC%pred) 
showed a significant positive correlation with TBPaCO2: r=0.60, p=0.05. 
No significant correlations existed between TBPaCO2 and the hypercapnic ventilatory 
response, r=0.13, p=0.7. 
Correlation-coefficient for TBPaCO2 and PImax(kpa) was -0.64, p=0.02 and for 
TBPaCO2 and PImax(%predicted) r=-0.70, p=0.01. For TBPaCO2 and PEmax(kpa) and 
TBPaCO2 and PEmax(%pred) there was no significant correlation: r=-0.04, p=0.9 and 
r=-0.08, p=0.8 respectively. 
Respiratory muscle endurance capacity (SIPmax) showed no significant correlation 
with PaCO2, r=-0.30, p=0.4. 
Borg score showed no significant correlation with TBPaCO2: r=0.47, p=0.13. 
 
Comparison of mean values 
A significant difference between the normocapnic group and the hypercapnic group 
was found in FEV1 as percentage from predicted; 62 (12)% versus 38 (16)%, p=0.05. 
However the amount of airway obstruction was not significantly different; in the 
normocapnic group and the hypercapnic group, FEV1/FVC was 48 (12)% and 36 
(11)% respectively, p=0.13. 
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FRC as percentage of predicted showed a significant difference between the groups: 
normocapnic 106 (22)% versus hypercapnic 143 (18)%, p=0.02. (table 1) 
There was no significant difference in hypercapnic ventilatory response between the 
groups.  
 
PImax and PEmax were not statistically different between both groups. (table 1) 
 
There was a significant difference between the normocapnic and the hypercapnic 
group for respiratory muscle endurance capacity (SIPmax); 2.4 (1.6) kPa versus 1.5 
(1.9) kPa respectively, p=0.04. (table 1) 
 
A statistically significant difference in the Borg score at the end of tube breathing was 
found between both groups: 6 (2) in the normocapnic group versus 9 (1) in the 
hypercapnic group. (table 1) 
 
Oxygen saturation at the end of tube breathing did not differ significantly between the 
groups. (table 1) 
 
DISCUSSION 
The results of this study indicate that in patients with moderate and severe COPD, 
hyperinflation and diminished respiratory muscle endurance capacity are associated 
with hypercapnia during tube-breathing. Due to the high load on the respiratory 
muscles, and the increased chemical drive, the hypercapnic patients experienced 
more dyspnea. 
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To our knowledge, this is the first study evaluating the effect of tube-breathing, as a 
possible respiratory muscle endurance training modality, on CO2-homeostasis in 
COPD patients. These patients may benefit from respiratory muscle endurance 
training, which requires complicated and expensive equipment. Tube-breathing is a 
simple and inexpensive way to perform RMET, which is accessible to almost all 
patients and chest-physicians. 
 
Patients in the hypercapnic group had a lower FEV1 (% predicted) compared to the 
normocapnic group. They also were more hyper-inflated as shown by a higher FRC 
(% predicted). Their diffusion capacity appeared to be lower, although not statistically 
significant. All these parameters point out that the patients in the hypercapnic group 
had more severe COPD. The increased FRC is of special importance in the 
explanation of the results of this study. It is well known that hyperinflation of the lungs 
leads to an unfavourable position of the diaphragm on its length-force diagram.21 The 
lungs and thorax are in the upper horizontal part of the pressure-volume curve, and 
consequently are stiffer. Muscle fibres not only produce substantially less active force 
at shorter lengths than optimal length, they also fatigue more rapidly.22 Fatigue is 
defined as a condition in which there is a loss in the capacity for developing force 
and/or velocity of a muscle, resulting from muscle activity under load, and which is 
reversible by rest.22 The finding of the lower SIPmax in the hypercapnic group, as a 
parameter for respiratory muscle endurance capacity and the correlation between 
Pimax and TBPaCO2 supports this finding. Mador and colleagues have shown that 
contractile fatigue of the diaphragmatic occurs after voluntary hyperpnea until task 
failure, even in healthy subjects.23 Voluntary hyperpnea is based on endurance 
exercise of the respiratory muscles. This is in accordance with our findings. These 
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factors all contribute to pump failure of the respiratory system, which leads to alveolar 
hypoventilation and thus hypercapnia.  
Patients in the hypercapnic group experienced more dyspnea at the end of tube-
breathing, compared to the normocapnic patients. This is reflected by a significant 
difference in the Borg score of 9 versus 6, p=0.007. Dyspnea is defined as a 
subjective experience of breathing discomfort that consists of qualitatively distinct 
sensations that vary in intensity.24 It is therefore a multi-factorial sensation that arises 
from different pathophysiological mechanisms. One of these mechanisms is the 
sense of respiratory muscular effort, which is related to the ratio of the pressure 
generated by the respiratory muscles to the maximum pressure-generating capacity 
of the muscles. This sense of effort may be the predominant factor contributing to 
breathlessness when the respiratory muscles are fatigued or weakened, or when the 
load on them is increased.25 Another mechanism contributing to dyspnea is 
hypercapnia. Hypercapnia caused breathlessness in the absence of respiratory-
muscle activity in paralysed (neuromuscular-blocking drug) healthy subjects. The 
same results were found in ventilator dependent patients with quadriplegia, who lack 
inspiratory muscle function and had air-hunger when end-tidal carbon dioxide was 
raised.24 The effects of carbon dioxide on dyspnea are mediated through changes in 
pH at the level of (central) chemo receptors.24 Patients in our study had the same 
ventilatory response to carbon dioxide. The difference in paCO2 at the end of tube 
breathing therefore does not seem to be a result of a different sensitivity of the 
chemoreceptor-system for carbon dioxide. Hypercapnia thus is an indicator of a weak 
and fatigable respiratory pump. It could be hypothesized that these patients might 
benefit most from RMET. However, further studies will be needed to evaluate this. 
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In summary, it is likely that the increased load on the respiratory muscles had more 
impact on the patients with diminished respiratory muscle capacity (i.e. the 
hypercapnic group), than on the patients who stayed normocapnic during tube 
breathing. The (fast) change in PaCO2 also contributes to the increased dyspnea. 
Thus, both factors led to a higher dyspnea sensation in the hypercapnic patients. 
Consequently, hyperinflated COPD patients with reduced capacity of the respiratory 
muscles, are probably prone to respiratory failure, hypercapnia and progressive 
dyspnea. Therefore they might be the most adequate patients for respiratory muscle 
endurance training. 
 
One of the limitations of this study is the small number of patients. However, 
correlations and comparison of means even in this small group point in the same 
direction. Another limitation is the fact that we did not measure diaphragmatic fatigue 
strictly speaking. This can be done by cervical magnetic stimulation or 
transcutaneous phrenic nerve stimulation.23 In our study we only looked at 
hypercapnia, which is caused by alveolar hypoventilation and thus is an indirect 
measurement of pump failure of the respiratory muscles. Our study was also not 
designed to look at dynamic hyperinflation. The protocol we used for tube-breathing, 
might have led to (more) dynamic hyperinflation, especially in those patients with 
more severe airflow obstruction. However, to minimize the possibility of dynamic 
hyperinflation we enforced patients (by means of the settings of the metronome) to 
breathe with a normal inspiratory ratio: expiratory ratio of 1:2 (Ti/Ttot= 0.33). Neither 
did we look at differences in lung compliance (loss of elastic recoil) between the 
subjects. Both factors might contribute to increased dyspnea and respiratory muscle 
fatigue.24 
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With the results of this study and the above mentioned remarks in mind, it would be 
interesting to find out whether diaphragmatic fatigue occurs during tube-breathing 
and whether hypercapnic patients would benefit more from endurance respiratory 
muscle training , than normocapnic patients.  
 
In conclusion, the results of this study show that impaired respiratory muscle capacity 
leads to hypercapnia and a higher perception of dyspnea during tube-breathing in 
patients with moderate and severe COPD. The ventilatory controlling system does 
not seem to be an important factor in becoming hypercapnic (won’t breathe). 
However the controlled system (respiratory pump) seems to be the determinant of 
hypercapnia during tube breathing (can’t breathe). Further studies are needed to 
evaluate which patients will benefit most from RMET. 
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ABSTRACT 
Background: Impaired exercise tolerance is frequently observed in patients with 
chronic obstructive pulmonary disease (COPD). Respiratory muscle strength training 
has been applied in COPD patients, to improve respiratory muscle function and 
exercise performance. Respiratory Muscle Endurance Training (RMET) by means of 
normocapnic hyperpnea is probably a better technique for improving endurance 
respiratory muscle function, which is required during exercise. This technique is not 
applied on a large scale because complicated and expensive equipment is needed to 
maintain CO2 homeostasis. This CO2 homeostasis can be preserved during 
hyperpnea by enlarging the dead space of the ventilatory system by breathing 
through a tube. Therefore, tube-breathing might be a new, inexpensive method for 
home-based RMET.  
The aim of this study was to asses whether home-based RMET by means of tube 
breathing improves endurance exercise performance and perception-of-dyspnea in 
patients with COPD.  
Methods: We randomised 36 patients with moderate and severe COPD (GOLD II 
and III) to RMET (n=18) by means of paced tube-breathing or to sham training 
(control: n=18). Both groups trained twice daily for 15 minutes, 7 days per week, 
during 5 weeks.  
Results: Endurance exercise capacity, determined by constant-load exercise testing 
on a cycle-ergometer, showed a significant increase of endurance time in the RMET-
group: 18 minutes ±648 seconds to 28 minutes ±894 seconds (mean±SD), p<0.001, 
whereas perception-of-dyspnea (Borg-score) decreased from 8.4±1.9 to 5.4±1.3, 
p<0.001. Respiratory muscle endurance capacity significantly increased in the 
RMET-group: sustainable inspiratory pressure increased from 25±9 to 31±14 cm H2O 
 64 
Effect of RMET on exercise performance 
, p=0.005. Quality of life (Chronic Respiratory Disease Questionnaire) improved from 
78.7±20.6 to 86.6±18.4, p=0.001. The control group showed no significant changes. 
Conclusion: Home-based RMET by means of tube-breathing leads to a significant 
improvement of endurance exercise capacity, a reduction in perception-of-dyspnea 
and an improvement in quality of life in patients with moderate to severe COPD.  
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INTRODUCTION 
Impaired exercise tolerance and diminished ventilatory efficiency are frequently 
observed in patients with chronic obstructive pulmonary disease (COPD). Airflow 
limitation leads to altered ventilation-perfusion matching and hyperinflation, which 
decreases effective alveolar ventilation and reduces ventilatory efficiency. Increased 
airway resistance also leads to increased work of breathing.1 In COPD patients, low 
maximal respiratory pressures have been observed.2 This is indicative of diminished 
respiratory muscle function, due to respiratory muscle weakness, due to 
hyperinflation, or a combination of these, which contributes to impaired exercise 
tolerance and dyspnea.  
Several forms of respiratory muscle training have been applied in patients with 
COPD, to improve respiratory muscle function and, to some extent, dyspnea and 
exercise performance. Most of these studies used respiratory muscle strength 
training and showed inconsistent results regarding improvements of dyspnea and 
exercise capacity.3-9 Respiratory Muscle Endurance Training (RMET) by means of 
normocapnic hyperpnea is probably a better technique for improving respiratory 
muscle endurance capacity, which is required during exercise.10 This technique is not 
applied on a large scale because complicated and expensive equipment is needed to 
maintain CO2 homeostasis during a period of hyperpnea.11-13 This CO2 homeostasis 
can also be preserved during hyperpnea by enlarging the dead space of the 
ventilatory system by breathing through a tube.  
 
We therefore hypothesized that RMET by means of tube-breathing might be a simple 
and inexpensive technique to improve respiratory muscle performance and exercise 
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capacity in patients with COPD, and thus might become available for routine clinical 
use.  
 
The aim of this randomised controlled trial was to test the effectiveness of RMET by 
means of tube-breathing on endurance exercise capacity in patients with moderate to 
severe COPD. The effects on respiratory muscle function, perception of dyspnea and 
quality of life were also evaluated. 
 
SUBJECTS AND METHODS 
 
Subjects 
Subjects were recruited from the waiting list of participants for pulmonary 
rehabilitation in the Department of Pulmonology Dekkerswald, University Medical 
Center Nijmegen. Consecutive patients, who met the inclusion criteria, agreed to 
participate and had signed the informed consent form were randomly assigned to an 
RMET group or a control group (sham training). The study protocol was approved by 
the Ethics Committee of the University Hospital Nijmegen. Inclusion criteria were: 1) 
Chronic airflow obstruction defined as an FEV1/FVC<70%, FEV1: 30-80% predicted, 
post bronchodilatation. 2) Stable clinical condition for at least 6 weeks. Exclusion 
criteria were: 1) Hypoxemia at rest or during exercise. 2) Cardiac or orthopaedic 
disease. 3) Body Mass Index (BMI) > 30 kg/m2. 
All patients on the waiting list for pulmonary rehabilitation (n=92) were screened 
between July 2001 and November 2002. Three patients refused to participate and 50 
patients met the exclusion criteria. (FEV1<30%predicted and/or hypoxemia at rest or 
during exercise : n=46, BMI>30: n=3 , orthopaedic disease: n=1). Initially 39 patients 
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were included in the study. Three patients dropped out of the study (severe 
exacerbation requiring hospitalization, 2 controls and 1 study-group). Thirty-six 
patients completed the study. 
Table 1 shows the baseline characteristics of the subjects. There were no significant 
differences between the groups. Age ranged from 38 to 73 years (56±8) (mean±SD). 
All patients used bronchodilators (long acting beta-agonists and short or long acting 
anti-cholinergics). Inhaled corticosteroids were used by 13 patients in the RMET 
group versus 12 in control group, and aminophylline was used by 2 patients in both 
groups. The use of medication did not differ significantly between groups. Medication 
was not changed during the study period. None of the patients had participated in a 
previous rehabilitation program. 
  
Study protocol 
Standardized tests were performed before the start (baseline), and in the last week of 
the training-period. Baseline testing was performed by the investigator. All other tests 
were performed by a doctor and physiotherapist, who were not aware of baseline 
results, nor the training device that was used by the patient. 
 
Pulmonary function testing, measurement of peak oxygen consumption (Vo2peak), 
maximal respiratory muscle strength and BMI were performed during the screening 
for pulmonary rehabilitation. If patients were suitable for participation, supplementary 
tests were performed within 1 week. 
 
On the first day of the study patients performed an inspiratory muscle endurance test 
(Incremental Threshold Loading).14 After 30 minutes of rest a hyperpnea endurance 
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test was done . After another 30 minutes of rest a 6-minutes walking distance test 
was carried out.15 The chronic respiratory disease questionnaire (CRQ) for 
measurement of health-related quality of life was completed.16 
 
On the second day Incremental Threshold Loading (30 minutes rest), hyperpnea 
endurance test (30 minutes rest) and 6-minutes walking distance test were repeated 
followed by (30 minutes rest) an endurance test on a cycle-ergometer.  
The best results were taken for analysis. 
 
Patients of both groups were told that they were undergoing respiratory muscle 
exercises, and that two different devices were being compared for this purpose. 
 
Testing 
Pulmonary function testing: 
A complete pulmonary function study was performed according to the statement of 
the European Respiratory Society.17 
 
Measurement of respiratory muscle performance: 
Maximal inspiratory and expiratory pressures (Pimax, Pemax) were measured in 
sitting position at residual volume and total lung capacity, respectively, using a 
flanged mouthpiece with a small air leak. The pressure was measured with a 
transducer (Validyne DP103-32, Northridge, California, USA) and recorded (Kipp & 
Zonen, BD 101, Delft, the Netherlands). Measurements of plateau values were taken. 
Reference normal values were taken from Wilson.18  
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Table 1: Baseline characteristics 
 RMET Control-group P value 
N 18 18  
age (yrs) 54.4 (7.7) 57.0 (8.5) 0.35 
sex M/F 8/10 9/9 0.75 
BMI (kg/m2) 26.7 (5.0) 27.5 (3.3) 0.61 
FEV1 (litres) 1.5 (0.4) 1.7 (0.5) 0.15 
FEV1 %pred 50 (14) 58 (15) 0.10 
FEV1/IVC 46 (13) 50 (14) 0.47 
RV %pred 137 (38) 127 (26) 0.36 
Pimax (cm H2O) 69 (29) 72 (23) 0.69 
Pimax %pred 89 (34) 93 (28) 0.73 
HET (sec) 534 (349) 389 (265) 0.17 
SIPmax (cm H2O) 25 (9) 29 (12) 0.37 
Wmax CPET 111 (33) 123 (35) 0.29 
Wmax %pred CPET 65 (16) 67 (15) 0.66 
VO2peak (ml/min/kg) 19.6 (4.5) 19.3 (4.0) 0.85 
6-MWD (metres) 519 (89) 550 (75) 0.27 
6-MWD %pred 92 (15) 100 (12) 0.09 
CLET (minutes seconds) 17 51 (10 48) 16 24 (15 30) 0.75 
BORG dyspnea CLET: iso-time 80% 8.4 (1.9) 8.3 (1.7) 0.78 
CRQ 78.7 (20.6) 82.4 (14.7) 0.5 
Data are expressed as means (SD) 
Legend to Table 1. 
BMI = body mass index;  
FEV1 = forced expiratory volume in 1 second;  
%pred = percentage predicted of reference values;  
IVC = inspiratory vital capacity;  
RV = residual volume;  
Pimax = maximal inspiratory mouth pressure;  
HET = hyperpnea endurance test;  
SIPmax = maximal sustainable inspiratory mouth pressure;  
Wmax = maximal work load in watt;  
CPET = cardio pulmonary exercise testing;  
VO2peak = peak oxygen uptake;  
6-MWD = 6-minutes walking distance;  
CLET = constant load exercise test on cycle ergometer;  
CRQ = Chronic Respiratory Disease Questionnaire 
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Inspiratory muscle endurance was measured by Incremental Threshold Loading.19 
Patients inspired against a weighted inspiratory valve, of which the load was 
increased at regular intervals. Threshold pressure was measured with a pressure 
transducer (Validyne DP103-32, Northridge, California, USA). The pressure achieved 
during the heaviest load tolerated for at least 45 seconds was defined as the maximal 
sustainable inspiratory pressure (SIPmax).14 
 
A hyperpnea endurance test (HET) was used to assess endurance performance of 
respiratory muscles. Subjects, wearing a nose-clip, breathed in a closed spirometer 
circuit (Godart, Bilthoven, the Netherlands) in which the soda lime absorber could be 
partially bypassed to maintain an isocapnic situation during the test . Oxygen was 
supplemented. End-tidal PCO2 (PetCO2) was measured at the mouth (Drager, Typ 
8290000) and oxygen saturation was monitored with a pulse oximeter. Patients 
breathed with a fixed frequency of 30 times a minute, Ti/Ttot=1:3, using an electronic 
metronome (Qwik Time QT5) and with a tidal volume of 45% of their vital capacity 
(IVC). They had visual feedback of their tidal volumes on the spirometer and were 
not encouraged during the test. The test was terminated when the patient could no 
longer sustain the respiratory frequency or tidal volume during 3 consecutive breaths 
or after a maximum of 20 minutes and this time was recorded.  
 
Exercise testing: 
Maximal incremental cardio-pulmonary exercise testing (CPET) was performed on an 
electrically-braked cycle ergometer ( Lode, Groningen, The Netherlands). During this 
symptom-limited test the work rate increased every 30 seconds by 5% of the 
predicted maximal work load 20 and pedalling rate was set at about 60 revolutions per 
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minute. Ventilatory parameters were measured breath by breath (sensormedics 
Vmax 29). Arterial blood samples were taken at regular intervals. Heart rate was 
monitored by ECG recording. At the end of the test Vo2peak and Wmax were recorded. 
Results were compared (pre- and post- training) at identical levels of exercise: iso-
work-load. Wmax of the first CPET was set at 100%. 
 
Endurance test or constant-load exercise testing (CLET) was performed on the same 
cycle-ergometer. Patients exercised at a work rate of 50% of the individual Wmax, 
pedalling rate 60 revolutions per minute. They were not encouraged during the test. 
The test was terminated when patients indicated that they were exhausted and were 
unable to maintain a pedalling frequency of 60 revolutions per minute. This time was 
recorded as cycle-endurance time. Ventilatory parameters were measured. 
Perception of dyspnea was measured by Borg scores at regular intervals.21 Results 
(pre- and post- training) were compared at identical time-points of exercise: iso-work-
time. The endurance time of the first CLET was set at 100%. 
 
Six-minute walking test was performed in a standardized way 15 in a corridor of 50 
meters length.  
 
Endurance respiratory muscle training and sham-training 
 
Respiratory muscle endurance training 
RMET was performed by means of tube-breathing. A tube (internal diameter 3 cm), 
connected to a mouthpiece, was added to the respiratory system to re-breathe 
exhaled carbon dioxide. Maximum ventilatory capacity that can be sustained for 15 
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minutes is about 60% of MVV. 22 Therefore, the aimed level of ventilation during 
training was set at 60% of Maximum Voluntary Ventilation (MVV) which was 
calculated from 35 times FEV1 (60% MVV= 0.6 x 35 x FEV1). The dead space was 
adjusted to 60% of the patients inspiratory vital capacity (IVC) + the resting tidal 
volume 23, because during exercise, when minute ventilation rises, tidal volume 
increases to about 60% of the vital capacity and remains constant thereafter.24 
Breathing frequency (Fresp) was calculated: 60% MVV= Fresp x (0.6 x IVC + resting 
tidal volume) and was increased during training to a maximum of 20 breaths per 
minute. Breathing frequency was imposed by an electronic metronome: Ti/Ttot ratio 
of 0.33 (Qwik Time QT5). Patients wore a nose-clip and were instructed to take deep 
breaths. End-tidal CO2 (PetCO2) was analysed with a sampling capnograph (Drager, 
Type 8290000) which was connected to the mouthpiece. 
 
Sham training 
Sham training was performed by breathing 6-7 times/minute through an incentive 
flowmeter (Inspirx, Resprecare Medical Inc, The Hague, The Netherlands). Airflow 
resistance was set at ± 5%Pimax.  
 
Training intensity  
Patients in both groups trained twice daily for 15 minutes, 7 days a week, during 5 
weeks. All patients were seen weekly at the pulmonary laboratory to check whether 
training was performed correctly. Furthermore, patients completed a diary in which 
they reported training regimen. 
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Statistics 
Data are reported as mean ± standard deviation (SD). 
Training induced changes (post- minus pre-training values: delta) were compared 
between groups using Analysis of Covariance (ANCOVA) with baseline as covariable 
(P-delta). The Students t-test for paired samples was used to evaluate differences 
within groups (pre- versus post- training). Significance was set at p≤0.05. SPSS 10.0 
for Windows was used for analysis. Endurance time of the CLET will be the primary 
endpoint. This study was initially powered to detect differences between 3 treatment 
arms. To demonstrate a difference in change of CLET of 15% between either of 2 
active treatments and no treatment, 20 subjects per group are needed, assuming a 
standard deviation of 15% in the change, a significance level of 2.5% per comparison 
and a power of 80%. Since one active treatment arm was dropped soon after start of 
the study (for financial reasons only), the significance level for the final analysis was 
raised to 5%. Hence, 17 subjects per group would suffice to attain a power of 80%. 
 
RESULTS 
Respiratory muscle performance 
Table 2 shows the effects of 5 weeks of home-based RMET on respiratory muscle 
performance. HET and SIPmax significantly increased in the RMET-group. The 
control group showed a decrease of these parameters. Pimax and Pemax showed no 
significant changes. Subset analysis of patients with a low Pimax (<75% predicted, 
n=6 in RMET-group and n=5 in control group), as indicative of respiratory muscle 
weakness, showed the same results in HET and SIPmax and moreover Pimax 
increased significantly in the RMET-group from 39 cm H2O (=54% pred) to 58 cm 
H2O (=80% pred), p=0.049. No changes occurred in the control group. 
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Exercise performance and quality of life 
The effects of home-based RMET on exercise performance and quality of life are 
shown in table 2.  
Endurance exercise capacity (CLET) significantly increased by 58% in the RMET-
group, whereas no change was found in the control group. 6-MWD and quality of life 
also showed a significant increase in the RMET-group, without a change in the 
control group.  
 
At an iso-work-time of 80% of the initial endurance time there were significant 
changes in the RMET-group for the following variables (table 3): Ventilation 
decreased from 42.8±10.5 to 39.6±10.0 litres/minute; p=0.034, respiratory frequency 
decreased from 37±7 to 30±7 breaths/minute; p<0.001 and tidal volume increased 
from 1.2±0.3 to 1.4±0.5 litre; p=0.035. Borg score for exercise dyspnea at iso-work-
time significantly decreased in the RMET-group from 8.4±1.9 to 5.4±1.3, p<0.001. In 
the control group there were no significant changes for these parameters.  
 
CPET showed a significant increase in maximal work-load in the RMET-group. (table 
2) Vo2peak did not change. At an iso-work load of 80% the following changes were 
observed in the RMET-group: Minute ventilation, respiratory rate, Vo2 and heart-rate 
all significantly decreased. No significant changes were observed in the control 
group. (table 4) 
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Table 2:  Pre and post training values and significance of training induced changes  
 RMET Control-group  
 pre post P-value 
within 
group 
pre post P-value 
within 
group 
P-delta 
Pulmonary 
function 
tests 
  
FEV1 (litres) 1.5(0.4) 1.6(0.5) 0.12 1.7(0.5) 1.8(0.5) 0.18 0.84 
IVC (litres) 3.3(0.7) 3.3(0.7) 0.26 3.6(0.9) 3.7(0.9) 0.10 0.52 
Respiratory 
muscle 
performance 
  
Pimax (H2O) 66(29) 73(28) 0.10 72(23) 75(30) 0.72 0.53 
Pemax (H2O) 75(34) 88(42) 0.13 82(34) 92(41) 0.38 0.94 
HET (sec) 534(349) 833(348) <0.001 389(265) 343(259) 0.05 <0.001 
Sipmax (H2O) 25(09) 31(14) 0.005 29(12) 26(12) 0.04 <0.001 
Exercise 
performance 
and CRQ 
  
CLET (minsec) 1751(1048) 2816(1454) <0.001 1624(1530) 1635(1402) 0.85 <0.001 
6-MWD (m) 512(86) 535(77) 0.007 549(75) 544(85) 0.48 0.02 
Wmax CPET 111 (33) 120 (38) 0.02 123 (35) 126 (42) 0.5 0.07 
VO2peak 
(ml/min/kg) 
19.6(4.5) 19.9(4.7) 0.33 19.3(4.0) 19.9(5.1) 0.51 0.93 
CRQ 78.7(20.6) 86.6(18.4) 0.001 82.4(14.7) 85.0(15.0) 0.2 0.07 
Data are expressed as means (SD).   P delta: significance of training induced changes (post- 
minus pre-training values: delta) between groups by ANCOVA. 
Legend to table 2. 
FEV1 = forced expiratory volume in 1 second;  
IVC = inspiratory vital capacity;  
Pimax = maximal inspiratory mouth pressure;  
Pemax = maximal expiratory mouth pressure;  
HET = hyperpnea endurance test;  
SIPmax = maximal sustainable inspiratory mouth pressure;  
6-MWD = 6-minutes walking distance;  
CLET = constant load exercise test on cycle ergometer;  
Wmax = maximal work load in watt;  
CPET = cardio pulmonary exercise testing;  
VO2peak = peak oxygen uptake;  
CRQ = Chronic Respiratory Disease Questionnaire 
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Table 3:  CLET: iso-work-time 80% 
  Pre and post training values and significance of training induced changes  
RMET Control-group  
 pre post P-value 
within 
group 
pre post P-value 
within 
group 
P-delta 
Ventilation l/min 42.8 (10.5) 39.6 (10.0) 0.034 40.9 (8.6) 43.3 (8.9) 0.33 0.03 
Resp. rate  37 (7) 30 (7) <0.001 32 (6) 32 (6) 0.50 0.05 
Tidal volume (l) 1.2 (0.3) 1.4 (0.5) 0.035 1.3 (0.3) 1.3 (0.3) 0.45 0.6 
BORG dyspnea  8.4 (1.9) 5.4 (1.3) <0.001 8.3 (1.7) 7.2 (2.2) 0.23 0.02 
Data are expressed as means (SD). 
P delta: significance of training induced changes (post- minus pre-training values: delta) 
between groups by ANCOVA. 
Endurance time of first CLET=100% 
Resp. rate = respiratory rate in breaths per minute 
 
 
Table 4:  CPET: iso-work-load 80% Wmax 
  Pre and post training values and significance of training induced changes
    
RMET Control-group 
 pre post P-value 
within 
group 
pre post P-
value 
within 
group 
P-delta 
Ventilation l/min 53.5 (14.8)  47.9 (15.1) 0.01 53.7 (10.4) 52.0 (12.7) 0.16 0.09 
Resp. rate 40 (7) 32 (5) 0.002 36 (5) 34 (5) 0.13 0.12 
Vo2 l/min 1.52 (0.41) 1.42 (0.41) 0.01 1.52 (0.42) 1.50 (0.47) 0.67 0.33 
Heart rate BPM 150 (17) 135 (16) 0.005 144 (17) 142 (17) 0.65 0.05 
Data are expressed as means (SD). 
P delta: significance of training induced changes (post- minus pre-training values: delta) 
between groups by ANCOVA. 
Maximal work-load of first CPET=100% 
Resp. rate = respiratory rate in breaths per minute;  
BPM = beats per minute 
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DISCUSSION 
The present study shows that home-based RMET by means of tube-breathing leads 
to a substantial improvement of endurance exercise capacity by 58%, an 
improvement in quality of life and a reduction in the perception of dyspnea, in 
patients with moderate and severe COPD. These findings suggest that this 
inexpensive technique can be a clinically relevant and easy applicable training 
intervention for COPD patients. 
 
To our knowledge, this is the first study using tube-breathing as home based 
respiratory muscle endurance training in COPD patients. We found an improvement 
in exercise endurance capacity of 58%. One other study showed an increase of 54% 
in submaximal cycling endurance exercise, after RMET in COPD patients. However 
RMET was not performed in a home-based setting and that study had no control 
group.25 Another study, performing home-based RMET in COPD, with a specially 
developed, expensive electromechanical device, reported an increase in submaximal 
treadmill exercise in the study-group compared to the control-group, that did not 
reach statistical significance.13 Furthermore, submaximal exercise on a treadmill has 
never been validated in COPD, whereas constant load exercise testing (CLET) on 
cycle ergometer has been proven to be a reproducible, reliable and valid method to 
assess endurance exercise capacity in patients with COPD.26,27 CLET can not only 
be used to measure endurance exercise time, but also to compare ventilatory and 
metabolic parameters at the same work-rate, before and after intervention. The latter 
being an effort independent measurement of training effects. Our study shows a 
change in breathing pattern after RMET. We found a lower minute ventilation, a lower 
breathing frequency and a larger tidal volume during CLET at iso-work-time 80%. 
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This change of breathing pattern has two major advantages. First, the ratio of dead 
space to tidal volume (Vd/Vt) decreases, which leads to an increase in effective 
alveolar ventilation. Secondly, it diminishes the work-of-breathing.1 It also indicates 
that respiratory muscle fatigue, leading to a rapid, shallow breathing pattern is 
delayed.28,29 These observations are supported by the finding that Borg-scores were 
significantly lower in the RMET-group at iso-time during CLET. This can be an 
additional explanation for the better performance during endurance exercise.30 Other 
studies using RMET in patients with COPD 13,25,31,32 do not report ventilatory 
parameters at iso-work-time. One study reported a decrease in strain index for 
ventilation, which means that a lower percentage of Vemax was necessary for a 
given workload.25 In accordance with the above mentioned clinical and home-based 
trial our results show improvement in endurance exercise time and improvements in 
ventilatory parameters. However, our study is the first to show that home based 
RMET by means of tube breathing, leads to a significant and clinically relevant 
improvement in endurance exercise capacity. 
 
Remarkably, maximal exercise capacity (Wmax) improved in the RMET-group by 8%, 
without a change in VO2peak. This can be explained by comparing parameters of 
CPET at iso-work load 80%, showing that minute ventilation, respiratory rate, VO2 
and heart-rate are significantly less after training, as a result of a more efficient way 
of breathing and less work of breathing. The reduction of minute ventilation and 
respiratory rate and their mutual relationship leads to an improvement of Vd/Vt. The 
decrease of VO2 by 100 ml/min at the same work-load can be a result of a better 
trained respiratory system in terms of oxidative capacity, requiring less oxygen for the 
same amount of work and thus a lower heart-rate. Translating these data to maximal 
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exercise capacity leads to an improvement of work-load at the same oxygen-
consumption. An increase in VO2peak of 19% was found in the only other study on 
home-based RMET in COPD patients. However, they did not speculate on the 
mechanism explaining this increase.13 Thus our results show effort independent 
improvements in cardio-circulatory and ventilatory parameters as a result of RMET. 
 
In accordance with improvements in endurance and maximal exercise capacity, 
patients in our RMET-group significantly improved 6-minutes walking distance by 5% 
(23 meters). Other studies showed improvements of 8 to 12 %. Although the 
improvement in 6-MWD was statistically significant, 23 meters do not seem to be 
clinically relevant.15 However, our patients had base-line values of 92% and 100% of 
reference values for 6-MWD (RMET and control respectively)33, and therefore great 
improvements were not expected. The fact that the RMET-group, in contrast to the 
control-group, significantly increased, in combination with a significant P-delta, 
indicates a true training effect. Therefore, functional exercise capacity, which is a 
useful outcome in evaluating the effects of respiratory muscle training34, improved as 
a result of home-based RMET. 
 
Improvements in exercise capacity can, in part, be explained by improved respiratory 
muscle function. Indeed, respiratory muscle endurance, measured by HET, 
significantly improved by 56% in the RMET-group. Previous studies using endurance 
respiratory muscle training as a training mode in patients with COPD showed 
improvements in maximal sustained ventilatory capacity (MSVC) of 29% 32 to 47% 35. 
Our results are comparable with these studies. Scherer reported an increase of 
258% in sustained ventilation13, using a different protocol. We terminated the 
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respiratory muscle endurance test after 20 minutes, because we were looking for 
improvements in respiratory muscle endurance capacity, and not for maximal results. 
The improvement in HET was confirmed by a significant improvement in incremental 
threshold loading. Therefore RMET by means of tube breathing leads to an 
improvement in respiratory muscle function. 
 
General exercise training, compared to isolated respiratory muscle training, is 
another way to train the respiratory muscles in a very specific way. General exercise 
training during 6 weeks indeed showed an improvement of exercise performance and 
respiratory muscle function.36 However, our study showed that training of the 
respiratory muscles without any other intervention, leads to an improvement of 
exercise capacity and respiratory muscle endurance performance. RMET can be 
performed in a home-based setting with minimal supervision, whereas general 
exercise training has to be performed in an institute. Furthermore, RMET can be 
seen as an add-on therapy to general exercise training. Ries et al. indeed showed 
that adding RMET to a rehabilitation program leads to an improvement in exercise 
capacity compared to a control-group receiving general exercise training only.32 
Future investigations are needed to evaluate whether starting RMET before the start 
of general exercise training or pulmonary rehabilitation leads to better outcomes of 
these programs in terms of exercise performance. 
 
One of the limitations of this study is the possibility of introducing a bias because 
patients included in our study were selected on the basis of an intended rehabilitation 
treatment for COPD, GOLD stage II and III. This means that these patients were 
highly motivated to improve their health status. However, motivation to perform this 
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time and energy consuming training is very important.13 Furthermore, neither 
respiratory muscle weakness nor ventilatory limitation were inclusion criteria. 
Analysis of our data shows only a slightly lowered Pimax compared to reference 
values. However, other studies even found improvements of respiratory muscle 
function and exercise capacity in normal sedentary subjects23 and in normal trained 
subjects 37,38 after endurance training of the respiratory muscles. Therefore RMET is 
also useful in subjects with normal respiratory muscle performance.  
 
The results of this study may have important clinical implications for the treatment of 
COPD patients. This easy applicable and inexpensive technique can be applied on a 
large scale. In this light, it can be added to the non-pharmacological therapeutic 
interventions in COPD, whereas respiratory muscle training until now is indicated, 
only along with a pulmonary rehabilitation program for selected patients with 
decreased respiratory muscle strength.39 Furthermore, when pulmonary 
rehabilitation, or even general exercise training is not available, home based RMET 
by means of tube breathing, can be a good alternative. In addition, home-based 
RMET resulted in a significant improvement in health-related quality of life, which is 
an important clinical outcome parameter in COPD patients.40 
In conclusion, the results of this study show that home-based RMET by means of 
tube breathing substantially improves endurance exercise capacity. It also improves 
quality of life and leads to a decrease of dyspnea in patients with moderate and 
severe COPD. Future investigations are needed to determine the effects of RMET in 
patients with very severe COPD, GOLD IV. Furthermore, it will be interesting to find 
out whether adding RMET to a pulmonary rehabilitation program might result in 
improvements of the outcomes of such a program. 
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ABSTRACT 
Background: Respiratory muscle weakness may contribute to dyspnea in patients 
with Chronic Obstructive Pulmonary Disease (COPD). Dyspnea leads to impaired 
exercise tolerance and adversely affects quality of life. Home-based respiratory 
muscle endurance training by means of tube-breathing is a new training mode, based 
on the principle of normocapnic hyperpnea. We hypothesized that home-based 
Respiratory Muscle Endurance Training (RMET) leads to an improvement of 
respiratory muscle endurance capacity, a reduction of dyspnea and an improvement 
in quality of life. 
Methods: Thirty-six patients with moderate to severe COPD (GOLD II and III) were 
randomized into two groups: RMET by means of tube-breathing (n=18) and sham 
training with an incentive spirometer (control: n=18). Patients in both groups trained 
twice daily, 15 minutes, 7 days a week during 5 weeks. Pulmonary function tests, 
respiratory muscle performance, dyspnea scores (BDI/TDI), and health-related 
quality of life (CRQ) were measured before and after training. 
Results: Patients in the RMET-group showed significant improvement of respiratory 
muscle endurance capacity. There was also a significant improvement in dyspnea 
and quality of life in the RMET-group: TDI-focal score increased by 2.8±2.5 points 
[mean±SD], p=0.001, CRQ-total score increased from 78.7±20.6 to 86.6±18.4, 
p=0.001. The control group showed no significant changes. 
Conclusions: Home-based RMET by means of tube breathing is a new method for 
endurance training of the respiratory muscles and it leads to an improvement of 
respiratory muscle endurance capacity, a reduction in dyspnea during daily activities, 
as well as an improvement in quality of life. 
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List of abbreviations 
BDI = baseline dyspnea index  
CO2 = carbon dioxide 
COPD = Chronic Obstructive Pulmonary Disease 
CRQ = Chronic Respiratory Disease Questionnaire 
 RMET = Respiratory Muscle Endurance Training  
ERS = European Respiratory Society 
FEV1 = forced expiratory volume in 1 second  
Fresp = respiratory frequency in breaths per minute 
FVC = forced vital capacity 
GOLD = Global Initiative for Chronic Obstructive Pulmonary Disease  
ITLet = incremental threshold loading endurance time 
IVC = inspiratory vital capacity  
MCID = minimum clinically important difference 
M/F = male/female  
MVV = maximum voluntary volume 
N = number of patients  
Pemax = maximal expiratory mouth pressure  
PetCO2 = end tidal CO2  
Pimax = maximal inspiratory mouth pressure 
QOL = Quality of Life  
RV = residual volume  
SD = standard deviation 
TDI = transition dyspnea index 
Ti = inspiratory time 
Ttot = total time of 1 respiratory cycle (in- and expiration) 
Yrs = years 
%pred = % of predicted value 
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INTRODUCTION 
Patients with Chronic Obstructive Pulmonary Disease (COPD) often seek medical 
help because of dyspnea. These patients become concerned when difficulty in 
breathing interferes with their ability to perform various daily activities and adversely 
affects their quality of life (QOL). One of the most important factors contributing to 
dyspnea is the work of breathing and the load on the respiratory muscles.1  
Impairment of expiratory flow, hyperinflation, increased work of breathing and 
increased dead space ventilation, also contribute to dyspnea.2 Respiratory muscle 
weakness is frequently observed in patients with COPD. This is reflected by lower 
maximal respiratory pressures in these patients3 and diminished respiratory muscle 
endurance.4 In summary, on the one hand there is an increased load on the 
respiratory muscles whereas on the other their capacity is less. These factors will 
aggravate the perception of dyspnea. 
Respiratory muscles can improve their capacity in response to training, and thus 
dyspnea and QOL might also improve. Indeed, respiratory muscle strength training 
by means of resistive training, may lead to a reduction of dyspnea5-9 and an 
improvement of QOL7 However, since natural breathing is non-resistive and since 
breathing frequencies during exercise may increase up to 60 breaths per minute, 
specific respiratory muscle endurance training (RMET) might be a much better 
training modality.10 RMET is based on normocapnic hyperpnea. Only one study 
looked at the effects of home-based RMET on dyspnea and quality of life. Indeed 
dyspnea and QOL improved, however the equipment that was used to remain 
normocapnic during a period of hyperpnea is very expensive11 and this prevents 
widespread use of this promising technique. CO2-homeostasis during hyperpnea can 
also be preserved by enlarging the dead space of the ventilatory system by breathing 
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through a tube. Tube breathing might be a very easy and inexpensive way to perform 
RMET. 
 
We hypothesized that tube-breathing, being a new and inexpensive method for 
home-based Respiratory Muscle Endurance Training, leads to an improvement of 
respiratory muscle function, a reduction of dyspnea and an improvement of Quality of 
Life in patients with COPD. 
 
SUBJECTS AND METHODS 
 
Subjects 
Thirty-six patients with moderate to severe COPD (FEV1/FVC<70%, FEV1 30%-80% 
predicted, post bronchodilatation), according to the guidelines of the Global Initiative 
for Chronic Obstructive Lung Disease (GOLD)12 were recruited for the study. All 
patients were on the waiting list of participants for pulmonary rehabilitation in the 
Department of Pulmonology Dekkerswald, University of Nijmegen. They were in a 
stable clinical condition for at least 6 weeks. Patients with hypoxemia at rest or during 
exercise or cardiac disease and poor compliance were excluded from participation. 
Patients who agreed to participate and had signed the informed consent form were 
randomly assigned to Respiratory Muscle Endurance Training (RMET-group) or to 
sham training (control-group). The study protocol was approved by the Ethics 
Committee of the University Hospital Nijmegen. Medication was not changed during 
the study period. Table 1 shows the baseline characteristics of the subjects. There 
were no significant differences in baseline characteristics between the two groups at 
the start of the study.  
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Table 1:  Baseline characteristics 
 RMET-group Control-group P value 
between groups 
n 18 18  
age (years) 54.4 (7.7) 57.0 (8.5) 0.4 
sex Male/Female 8/10 9/9 0.8 
Smoking (packyears) 33 (22) 34 (16) 0.9 
FEV1 (litres) 1.5 (0.4) 1.7 (0.5) 0.2 
FEV1(%predicted) 50 (14) 58 (15) 0.1 
FEV1/IVC 46 (13) 50 (14) 0.5 
RV (%predicted) 137 (38) 127 (26) 0.4 
Pimax (%predicted) 89 (34) 93 (28) 0.7 
ITLet (seconds) 760 (267) 892 (377) 0.2 
CRQ total 78.7 (20.6) 82.4 (14.7) 0.5 
CRQ dyspnea 18.1 (5.0) 19.6 (5.1) 0.4 
CRQ fatigue 14.1 (4.1) 14.8 (3.6) 0.6 
CRQ emotional function 29.1 (8.6) 29.4 (7.4) 0.9 
CRQ mastery 17.4 (5.2) 18.6 (4.9) 0.5 
BDI Focal score 5.0 (2.1) 5.7 (1.5) 0.3 
BDI functional impairment 1.5(1.0) 2.0 (0.6) 0.1 
BDI magnitude of task 1.8 (0.6) 1.9 (0.7) 0.4 
BDI magnitude of effort 1.8 (0.8) 1.8 (0.6) 0.95 
Data are expressed as mean (SD) 
Legend to table 1: 
RMET: Respiratory Muscle Endurance Training 
n: number of patients 
packyears: number of years that a subject smokes a mean of 20 cigarettes per day 
FEV1: Forced Expiratory Volume in 1 second 
IVC: Inspiratory Vital Capacity 
RV: Residual Volume 
Pimax: Maximal Inspiratory Pressure 
ITLet: Incremental Threshold Loading endurance time 
CRQ: Chronic Respiratory Disease Questionnaire 
BDI:  Baseline Dyspnea Index 
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Study protocol 
Baseline tests were performed before the start of the study. Subsequently patients 
exercised their respiratory muscles during 5 weeks by means of RMET or sham-
training. In the last week of this period patients were tested again. Testing was 
standardized.  
 
Patients performed pulmonary function tests, tests to asses respiratory muscle 
performance, followed by an interview and a questionnaire to assess dyspnea and 
health related quality of life. 
 
Patients of both groups were told that they were undergoing respiratory muscle 
exercises, and that two different devices were being compared for this purpose.  
 
TESTS 
 
Pulmonary function tests 
A complete pulmonary function study was performed according to ERS-standards.13 
 
Measurement of respiratory muscle performance 
Maximal in-and expiratory pressures (Pimax and Pemax) were measured in sitting 
position at residual volume and total lung capacity respectively. A flanged 
mouthpiece with a small air leak was connected to a pressure transducer (Validyne 
DP103-32, Northridge, California, USA). Mouth pressures were recorded on a chart 
recorder (Kipp & Zonen, BD 101, Delft, the Netherlands) and plateau values were 
taken for analysis. Reference values were taken from Wilson14  
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Incremental Threshold Loading was used to measure inspiratory muscle endurance. 
Patients inspired against a weighted inspiratory valve. They started with a load of 
10% of their Pimax and 25 gram weights were added at 1.5 minute intervals.15 The 
time during which a patient was able to breathe through the threshold device was 
defined as incremental threshold loading endurance time (ITLet). Borg scores were 
taken at regular intervals. Borg scores (pre- and post- training) were compared at 
identical time-points during the Incremental Threshold Loading test: iso-endurance 
time. The maximal endurance time of the first test was set at 100%. 
 
Assessment of dyspnea and health-related QOL  
Dyspnea during daily activities was assessed by Mahler’s Baseline and Transition 
Dyspnea Index (BDI/TDI).16;17 
Health-related quality of life was measured by the Chronic Respiratory Disease 
Questionnaire (CRQ). This questionnaire measures health-related quality of life in 
patients with COPD in four dimensions: dyspnea, fatigue, emotional function and 
mastery. The dyspnea category is strictly individualized. Altogether 20 items are 
scored on a seven-point scale (a higher score indicates a better quality of life).18;19 
 
Training protocol 
Patients in both groups trained twice daily for 15 minutes, 7 days a week, during 5 
weeks. All patients were checked in the pulmonary laboratory by means of a 15 
minute trial-run on adjustment and once a week thereafter. In the RMET-group, end-
tidal CO2 was analysed with a sampling capnograph (Drager, Typ 8290000) which 
was connected to the mouthpiece. Arterial oxygen saturation and heart rate were 
measured noninvasively by oximetry (Nonin Medical Inc. USA model 8500 MA). 
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Respiratory Muscle Endurance Training 
RMET was performed by means of tube breathing. We added an external dead 
space (mouthpiece+tube, internal diameter 3 cm) to the respiratory system, in order 
to maintain the partial pressure of arterial carbon dioxide within a normal range 
during voluntary hyperpnea. The aimed level of ventilation during training was set at 
60% of Maximum Voluntary Ventilation (MVV) which was calculated from 35 times 
FEV1 (60% MVV= 0.6x35xFEV1). The dead space was adjusted to 60% of the 
patient’s inspiratory vital capacity (IVC) + the resting tidal volume.20 Breathing 
frequency (Fresp) was calculated: 60% MVV= Fresp x (0.6 x IVC+ resting tidal volume) 
and was increased during training to a maximum of 20 breaths per minute. Breathing 
frequency was imposed by a metronome: Ti/Ttot ratio of 0.33 (Qwik Time QT5). 
Patients wore a nose-clip and were instructed to take deep breaths to overcome the 
large dead space.  
 
Sham training 
Sham training consisted of breathing exercises, 6-7 times a minute, on an incentive 
target-flowmeter (Inspirx, Resprecare Medical Inc, The Hague, The Netherlands). 
Airflow resistance was ± 5% of Pimax.  
 
Data Analysis 
Data are reported as mean ± standard deviation (SD). Training induced changes 
(post- minus pre-training values: delta) were compared between groups using 
Analysis of Covariance (ANCOVA) with baseline as covariable (P-delta). The 
Students t-test for paired samples was used to evaluate differences within groups 
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(pre- versus post- training). Significance was set at p≤0.05. SPSS 10.0 for Windows 
was used for analysis. 
 
RESULTS 
Pulmonary function tests 
Pulmonary function tests showed no significant change after the training period. 
(table 2) 
 
Table 2:  Pulmonary function and respiratory muscle performance 
 RMET Controls 
 pre post P-value 
within 
group 
pre post P-value 
within 
group 
P-Delta 
FEV1 (litres) 1.5(0.4) 1.6(0.5) 0.1 1.7(0.5) 1.8(0.5) 0.2 
IVC (litres) 3.3(0.7) 3.3(0.7) 0.3 3.6(0.9) 3.7(0.9) 0.1 
Pimax (kpa) 6.6(2.9) 7.3(2.8) 0.1 7.2(2.3) 7.5(3.0) 0.7 0.53 
Pemax (kpa) 7.5(3.4) 8.8(4.2) 0.1 8.2(3.4) 9.2(4.1) 0.4 0.94 
ITLet (seconds) 760(267) 974(434) 0.001 892(377) 790(381) 0.01 < 0.001 
Borg iso-80% 8.9(1.5) 8.1(1.5) 0.04 9.0(1.6) 8.6(1.5) 0.5 0.7 
pre and post training values: data are expressed as mean (SD) 
 
Legend to table 2: 
RMET: Respiratory Muscle Endurance Training 
FEV1: Forced Expiratory Volume in 1 second 
IVC: Inspiratory Vital Capacity 
Pimax: Maximal Inspiratory Pressure 
Pemax: Maximal Expiratory Pressure 
Kpa: kilopascal 
ITLet: Incremental Threshold Loading endurance time 
Borg iso-80%: Borg score for dyspnea at 80% of maximal time of the first Incremental 
Threshold Loading Test 
P-Delta:  significance of training induced changes (post- minus pre-training values: 
delta) between groups by ANCOVA 
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Respiratory muscle performance 
Respiratory muscle strength, measured by Pimax and Pemax showed no significant 
changes after training. (table 2) 
 
Respiratory muscle endurance performance, measured by incremental threshold 
loading (ITLet), significantly increased by 29% in the RMET-group from 12.6 to 16.2 
minutes. A significant decrease of 11% was observed in the control group. (table 2) 
The Borg-score at iso-endurance time 80% was significantly lower in the RMET-
group after training. Borg score decreased from 8.9±1.5 to 8.1±1.5, p=0.04. No 
change occurred in the control group. (table 2) 
 
Dyspnea 
Baseline Dyspnea Index values showed no significant differences between the two 
groups. Transitional Dyspnea Index (focal score) showed a significant improvement 
of dyspnea in daily activities in the RMET-group versus the control group: 2.8±2.5 
versus –0.2±1.6; p=0.001. There were also significant differences between the two 
groups for each category of the TDI. (table 3)  
 
Health-related quality of life 
The Chronic Respiratory Disease Questionnaire showed a significant improvement in 
total score and also in the domains dyspnea, fatigue and mastery in the RMET-
group. (table 4) The control group showed no significant changes. 
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Table 3:  Transition Dyspnea Index 
 RMET Controls 
 TDI TDI P-Delta  
Functional impairment +1.1 (0.9) +0.0 (0.6) 0.001 
Magnitude of task +0.9 (0.8) +0.1 (0.4) 0.001 
Magnitude of effort +0.8 (1.0) -0.3 (0.9) 0.005 
Focal score +2.8 (2.5) -0.2 (1.6) <0.001 
Post training values TDI: data are expressed as mean (SD) 
Legend to table 3: 
RMET:  Respiratory Muscle Endurance Training 
TDI:  Transition Dyspnea Index 
P-Delta:  significance of training induced changes (delta) between groups by ANCOVA 
 
Table 4:  Quality of life: CRQ  
 RMET Controls 
 pre post P-value 
within 
group 
pre post P-value 
within 
group 
P-
Delta  
CRQ total 78.7(20.6) 86.6(18.4) 0.001 82.4(14.7) 85(15) 0.2 0.07 
CRQ dyspnea 18.1(4.9) 20.9(4.8) 0.01 19.6(5.1) 19.9(5.0) 0.5 0.04 
CRQ fatigue 14.1(4.1) 15.7(4.4) 0.04 14.8(3.6) 15.5(3.7) 0.3 0.46 
CRQ emotional 
function 
29.1(8.6) 30.4(7.8) 0.1 29.4(7.4) 30.2(8.2) 0.2 0.58 
CRQ mastery 17.4(5.2) 19.4(4.7) <0.001 18.6(4.9) 19.3(5.0) 0.3 0.21 
pre and post training values: data are expressed as mean (SD) 
 
Legend to table 4: 
CRQ:  Chronic Respiratory Disease Questionnaire 
RMET:  Respiratory Muscle Endurance Training 
P-Delta:  significance of training induced changes (post- minus pre-training values: 
delta) between groups by ANCOVA  
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DISCUSSION 
The present study demonstrates that dyspnea during daily activities, quality of life 
and respiratory muscle function improve as a result of home-based RMET in patients 
with moderate to severe COPD. This implicates that specific endurance training of 
the respiratory muscles by means of tube-breathing, which is very easy applicable 
and inexpensive, contributes to an improvement in health-status in COPD patients.  
 
To our knowledge, this is the first study evaluating the effects of home-based-RMET 
by means of tube-breathing on dyspnea, QOL and respiratory muscle performance. 
Inspiratory muscle endurance as measured by incremental threshold loading, 
improved by 29% in the RMET-group. Previous studies also showed improvement of 
respiratory muscle endurance capacity after endurance training of the respiratory 
muscles. Improvements ranged from 29% to 47% and in one study even 258%11; 21-23 
However, different endurance tests of the respiratory muscles were used and 
therefore direct comparison of these results is not possible. Nevertheless, it can be 
concluded that respiratory muscle endurance capacity improves significantly as a 
result of specific endurance training. This improvement has its repercussion on the 
sensation of dyspnea. Comparing the post-training Borg scores with the ones 
reported at 80% of the first ITL (iso-endurance time 80%), shows that subjects in the 
RMET-group also experienced less dyspnea at the same time-point. This means that 
less dyspnea is perceived while the work-load for the respiratory muscles is the 
same. Thus, RMET by means of tube-breathing improves the endurance capacity of 
the respiratory muscles, and reduces the perception of dyspnea. 
 
Furthermore, dyspnea in daily activities significantly improved in the RMET-group, as 
reflected by a TDI of +2.8. (table 3). There were also significant differences between 
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the two groups for each category of the TDI, which means that patients were able to 
resume some of their daily activities they had abandoned because of dyspnea and 
perform greater efforts and tasks than prior to RMET. (table 3) The only other study 
that performed home-based endurance training of the respiratory muscles in COPD 
patients, also showed an increase in TDI, however there was no significant difference 
between the study group and the control group.11 Thus our study shows that 
significant improvements in dyspnea during daily activities can be obtained by RMET 
by means of tube-breathing. 
  
With these results in mind, the question still remains whether dyspnea improved only 
as a result of better respiratory muscle performance. It is well known that dyspnea is 
a multi-factorial problem, not solely dependent on respiratory muscle function. 
Dyspnea originates in the central nervous system because of an imbalance between 
the motor neural output to the respiratory muscles and the magnitude of ventilation 
resulting from it. Patients in the study group were enforced to increase their motor 
neural output daily during RMET. This may have led to an adaptation to this higher 
output, and thus a contribution to the reduction in dyspnea. This adaptation aspect 
cannot be excluded in our patients. Our findings of increased performance of the 
respiratory muscles support the concept that the balance between the load on the 
respiratory muscles, versus the working capacity of those muscles, is a major 
determinant of dyspnea. 
  
Health related quality of life, measured by CRQ total score, significantly increased in 
the RMET-group, whereas no significant change was found in the control group. 
Looking at the different subsets of the CRQ, the domain dyspnea showed a 
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significantly and clinically relevant improvement. This is in accordance with our 
results of the TDI. Patients not only experienced less dyspnea, they also had more 
feeling of control over their disease, reflected by a significant and clinically relevant 
increase in the domain mastery. Furthermore patients felt less fatigued.  
Other studies using RMET, did not measure quality of life21;23 except for Scherer et 
al. who used the SF-12 health questionnaire, consisting of a physical and mental 
component. Only the physical, but not the mental component of the SF-12 health 
survey, showed a significant increase in the study group.11 Some studies using 
resistive breathing, also measured quality of life. Larson and co-workers evaluated 
the effects of inspiratory (threshold) muscle training with and without cycle ergometry 
training on the domains dyspnea and fatigue of the CRQ. A control group received 
education only. They found a significant improvement of dyspnea in all groups, but 
no differences between the groups. Furthermore, there were no significant changes 
in the CRQ-fatigue domain.24 In another study patients were trained with inspiratory 
(threshold) muscle training. Two different training loads, 15% and 30% of Pimax, 
were compared. There were no changes in patients’ reports of functional impairment 
(Sickness Impact Profile), mood (Profile of Mood States) and health status (Health 
Perceptions Questionnaire).25 Thus, previous studies have shown that aspects of 
quality of life questionnaires can improve after respiratory muscle training. However, 
our study is the first to show an improvement of health-related quality of life after 
home-based RMET by means of tube-breathing. 
 
Irrespective of whether dyspnea or respiratory muscle deconditioning is the first 
phenomenon in patients with COPD, both aspects lead to a further decline in health 
status. The following model might explain this. (figure 1) Respiratory muscle 
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deconditioning contributes to dyspnea, which influences quality of life and mastery in 
a negative way. Dyspnea itself, leads to a decrease in physical activities, which acts 
negatively upon quality of life. A decline in physical activity leads to further 
deconditioning of the organism as a whole and consequently also of the respiratory 
muscles. In this way a negative loop is created that is intensifying itself. This finally 
leads to progressive dyspnea and severe impairment of quality of life. Our study 
validates this model, and shows that RMET interrupts this negative loop. RMET leads 
to an increased respiratory muscle endurance capacity, a reduction of dyspnea and 
an improvement of quality of life. 
 
Figure 1: relation of respiratory muscle function to dyspnea and quality of life in COPD 
patients: a model 
Respiratory muscle deconditioning
dyspnea
Physical activities
Inactivity and general deconditioning
quality of life and mastery
quality of life
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One of the limitations of this study is the fact that patients were selected from the 
waiting-list for pulmonary rehabilitation. This may have led to a bias because these 
patients are motivated to improve their health status. However, patients need to be 
motivated to perform this kind of endurance training of the respiratory muscles, which 
is time and energy consuming. 
 
The present findings may have implications for the non-pharmacological 
management of patients with moderate and severe COPD (GOLD II and III). It 
appears that home-based RMET by means of tube-breathing is successful in 
reducing dyspnea and improving quality of life. Furthermore it is not expensive and 
easy to perform. This enables its wide-spread use, even apart from a pulmonary 
rehabilitation program, whereas until now respiratory muscle training is only 
recommended for selected patients within a pulmonary rehabilitation program.26 
 
In summary, the results of this study show that home-based endurance training of the 
respiratory muscles by means of tube-breathing results in improvement of respiratory 
muscle endurance performance, dyspnea and health related quality of life in patients 
with moderate and severe COPD. Future investigations are needed to establish its 
role in conjunction with a pulmonary rehabilitation program and the role of adaptation 
of the patient to sensory perceptions from the respiratory muscles. Furthermore, it 
will be interesting to evaluate the effects of this training modality in very severe 
COPD (GOLD IV).  
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ABSTRACT 
Background: Respiratory muscle training can be used in pulmonary rehabilitation of 
patients with Chronic Obstructive Pulmonary Disease (COPD). Endurance training of 
the respiratory muscles, without any other intervention like general exercise training, 
results in improvement of exercise capacity. We therefore hypothesized that 
optimising the condition of the respiratory muscles by means of respiratory muscle 
endurance training before the start of pulmonary rehabilitation might lead to a better 
improvement of endurance exercise capacity after pulmonary rehabilitation.  
Methods: We randomised 36 patients with moderate to severe COPD to home-
based Respiratory Muscle Endurance Training (RMET: n=18) by paced tube-
breathing or sham training with an incentive flowmeter (control: n=18). Both groups 
trained twice daily for 15 minutes, during 17 weeks. Training started 5 weeks prior to 
the start of pulmonary rehabilitation and was continued until the end of rehabilitation.  
Results: Improvements in respiratory muscle capacity and exercise performance 
during the rehabilitation period were not statistically different between the groups. 
Quality of life and dyspnea during daily activities also improved to the same extent 
during rehabilitation in both groups. However, the improvement over the complete 
period of preceding respiratory muscle training and subsequent pulmonary 
rehabilitation was significantly better in patients who received RMET compared to the 
control group for the following variables: respiratory muscle endurance capacity, 
p<0.001; 6-minutes walking distance, p=0.02; endurance exercise capacity, p=0.03 
and dyspnea during exercise (Borg-score), p=0.01  
Conclusion: Optimising the respiratory muscles by means of RMET before the start 
of pulmonary rehabilitation, leads to a better outcome of such a program in terms of 
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improved exercise endurance capacity and a reduction of dyspnea during exercise in 
patients with moderate to severe COPD. 
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INTRODUCTION 
Respiratory muscle training can be considered within a pulmonary rehabilitation 
program especially in patients with Chronic Obstructive Pulmonary Disease (COPD) 
who have decreased ventilatory muscle strength.1 Studies have reported that 
addition of respiratory muscle training to a pulmonary rehabilitation program results in 
an increased strength and endurance of these muscles.2-4 However, the addition of 
respiratory muscle training to a pulmonary rehabilitation program does not always 
result in improvement of (maximal) exercise capacity.2-6 Patient selection, respiratory 
training modality and intensity may all have contributed to these diverse results. 
Furthermore, all studies investigated effects of respiratory muscle training as part of 
the pulmonary rehabilitation program. This may have less effect than applying 
respiratory muscle training before the start of the pulmonary rehabilitation program, 
since this may enhance training intensity due to a better trained ventilatory system 
and less dyspnea. Indeed, isolated home-based Respiratory Muscle Endurance 
Training (RMET) in patients with COPD has been shown to improve respiratory 
muscle function and reduce dyspnea.7 Both factors can contribute to higher tolerable 
training loads and thus may lead to better outcomes of exercise capacity after 
pulmonary rehabilitation. Furthermore, since the prevalence of COPD and therefore 
the need for pulmonary rehabilitation will increase dramatically over the coming 
years, the burden on rehabilitation programs will also increase.8 At present, many 
rehabilitation institutes in the Netherlands deal with considerable waiting lists. During 
such a period, home-based RMET can easily be applied. 
 So far no studies have been reported assessing the effects of optimising the 
respiratory muscles before the start of the pulmonary rehabilitation program.  
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We hypothesized that optimising the condition of the respiratory muscles before the 
start of pulmonary rehabilitation results in an improved exercise capacity because the 
efficiency of breathing improves and dyspnea decreases after RMET.  
We conducted a randomised controlled trial with home-based RMET before the start 
of pulmonary rehabilitation in patients with COPD and evaluated its effect on 
endurance exercise capacity, health related quality of life and dyspnea. 
 
METHODS 
Patients 
Patients were recruited from the waiting list for pulmonary rehabilitation in the 
Department of Pulmonary Diseases Dekkerswald, University of Nijmegen. Patients 
with moderate to severe COPD (FEV1/FVC<70% and FEV1 post-bronchodilatation 
between 30 and 80% predicted: GOLD II and III), in a stable clinical condition, were 
randomly assigned to a RMET group or a control group (sham training). Patients 
were not hypoxemic, neither at rest nor during maximal incremental exercise testing. 
They were free of any clinical evidence of cardiovascular or musculoskeletal disease 
and had a Body Mass Index (BMI) < 30 kg/m2. Initially 39 patients were included in 
the study. Three patients dropped out of the study (severe exacerbation requiring 
hospitalization, 2 controls and 1 in the study-group). Thirty-six patients completed the 
study. 
 
The protocol was approved by the Ethics Committee of the University Hospital 
Nijmegen and all patients gave written informed consent.  
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Pulmonary rehabilitation program 
Patients participated in a multidisciplinary in-patient program for 12 weeks, which 
consisted of exercise training, peripheral muscle training, education, nutritional and 
psycho-social support.9  
 
Study protocol 
Patients trained their respiratory muscles (RMET or sham training), in a standardised 
way after instruction by the investigator, from 5 weeks prior to the start of the 
pulmonary rehabilitation program until the end of this rehab-program. (Figure 1)  
 
Figure 1: Study protocol 
0 weeks 1 week    5 weeks      17 weeks 
 
 
test 1      test 2       test 3 
(baseline)   
   
 start training  start rehabilitation/    end rehabilitation/ 
(RMET or sham) continue training    end training 
 
 
Patients were clinically evaluated at baseline before the start of home-based RMET 
(test 1), 2 days before the start of pulmonary rehabilitation (test 2), and in the last 
week of the rehabilitation program (test 3).  
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Every test took three days. On the first day, pulmonary function testing,10 
measurement of maximal respiratory muscle strength, evaluation of nutritional status 
and measurement of Vo2peak were performed. On the second day patients performed 
respiratory muscle endurance tests. A quality of life questionnaire and a dyspnea 
questionnaire were completed. 6-minutes walking distance was performed. 
 
On the third day respiratory muscle endurance tests and the 6-minutes walking 
distance were repeated. Endurance testing on a cycle-ergometer was performed. 
Between all tests patients rested for 30 minutes. 
The best results of the tests were used for analysis. 
 
MEASUREMENTS 
 
Measurement of respiratory muscle performance 
Inspiratory muscle endurance: Incremental Threshold Loading was used to 
determine inspiratory muscle endurance.11;12 The pressure achieved during the 
heaviest load tolerated for at least 45 seconds was defined as the maximal 
sustainable inspiratory pressure (SIPmax).  
 
Respiratory muscle strength: Maximal inspiratory and expiratory plateau pressures 
(Pimax, Pemax) were measured at the mouth from RV and TLC, respectively. A 
flanged mouthpiece was connected to a transducer (Validyne DP103-32, Northridge, 
California, USA). The highest of at least 9 measurements was taken for analysis.13 
Reference values were taken from Wilson.14
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Respiratory muscle endurance: Performance of in- and expiratory muscles was 
assessed by a hyperpnea endurance test (HET). Patients breathed in a closed 
spirometer circuit (Godart, Bilthoven, the Netherlands) in which the soda lime 
absorber could be partially bypassed with a three way valve to maintain an isocapnic 
situation during the test . Oxygen was supplemented in quantities that kept the level 
of the spirometer constant. End-tidal PCO2 (PetCO2) was monitored at the mouth by a 
capnograph (Drager, Type 8290000). Arterial oxygen saturation (SaO2) was 
monitored with a pulse oximeter (Oxyshuttle, Sensor Medics, Bilthoven, The 
Netherlands). Patients were instructed to hyperventilate at 30 breaths/minute, 
Ti/Ttot=1:2. Visual feedback of the tidal volume (45% of their inspiratory vital 
capacity) was given on the spirometer. The test was stopped when the patient could 
no longer sustain the respiratory frequency or tidal volume during 3 consecutive 
breaths or after a maximum of 20 minutes. Time until the end of the test was 
recorded as hyperpnea endurance time (HET). Patients were not encouraged during 
the test. 
 
Health-related quality of life and Dyspnea 
Health-related quality of life and dyspnea were assessed by means of the Chronic 
Respiratory Disease Questionnaire (CRQ)15 and Mahler Transition Dyspnea Index 
(TDI).16;17 
 
Measurement of exercise performance 
Maximal exercise test: Maximal incremental cardio-pulmonary exercise testing 
(CPET) was performed. Work rate increased each 30 seconds by 5% of the 
predicted value.18 Minute ventilation, respiratory frequency, oxygen consumption and 
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carbon dioxide production as well as oxygen saturation were measured continuously 
(Sensormedics Vmax 29). Heart rate and blood-pressure were monitored.  
 
Endurance exercise test: constant-load bicycle exercise testing (CLET) was 
performed at a work rate of 50% of the individual Wmax. The test was stopped when 
patients were exhausted and could not maintain a pedalling frequency of 60/minute. 
This time was recorded as cycle-endurance time. Measurements of minute 
ventilation, respiratory frequency, oxygen consumption, carbon dioxide production 
and heart rate were performed. Perception of dyspnea was measured by means of 
Borg scores which were taken at the end of the test (CLET BORG).19 Patients were 
not encouraged during the test.  
 
6 minutes walking distance (6 MWD): 6 MWD was determined in a straight corridor of 
50 meters.20
 
Respiratory muscle endurance training and sham-training 
Respiratory muscle endurance training (RMET) 
RMET was performed by means of paced tube breathing. PaCO2 was kept within a 
normal range during hyperpnea by adding an external dead space (tube, internal 
diameter 3 cm) to the respiratory system. The aimed level of ventilation was set at 
60% of Maximum Voluntary Ventilation (MVV), calculated from 35 times FEV1 (60% 
MVV= 0.6 x 35 x FEV1). The dead space was adjusted to 60% of the patient’s 
inspiratory vital capacity (IVC) + the resting tidal volume,21 because during exercise, 
when minute ventilation rises, tidal volume increases to about 60% of the vital 
capacity and remains constant thereafter.22 Breathing frequency (Fresp) was 
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calculated: 60% MVV= Fresp x (0.6 x IVC+ resting tidal volume) and was increased 
during training to a maximum of 20 breaths per minute. Breathing frequency was 
imposed by a metronome: Ti/Ttot ratio of 0.33 (Qwik Time QT5). Patients wore a 
nose-clip and were instructed to take deep breaths. End-tidal CO2 (PetCO2) at the 
mouth was analysed with a sampling capnograph (Drager, Type 8290000). Arterial 
oxygen saturation and heart rate were measured (Nonin Medical Inc. USA model 
8500 MA). 
 
Sham training 
Sham training was performed by breathing 6-7 times/minute through an incentive 
flowmeter (Inspirx, Resprecare Medical Inc, The Hague, The Netherlands). Airflow 
resistance was set at ± 5%Pimax.  
 
All patients were instructed in the pulmonary laboratory by means of a 15 minute 
trial-run at the beginning of the study and weekly thereafter. They trained twice daily 
for 15 minutes, 7 days a week, during 5 weeks prior to pulmonary rehabilitation and 
subsequently during the 12-week in-patient pulmonary rehabilitation program.  
 
Statistical analysis 
Data are reported as mean ± standard deviation (SD), since values were normally 
distributed. For descriptive purposes, the Student’s t-test for paired samples was 
used to evaluate differences within groups. Training induced changes (post- minus 
pre-training values: test 3 minus test 1) were compared between groups using 
Analysis of Covariance (ANCOVA) with baseline as covariable and reflected as 
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‘delta’ (P-Delta). Significance was set at p≤0.05. SPSS 10.0 for Windows was used 
for analysis.  
 
RESULTS 
Baseline demographic data showed no significant differences between the groups 
(table 1).  
 
After the period of isolated home-based RMET and before the start of the 
rehabilitation (test 2) there were no significant differences between the RMET-group 
and the control-group in pulmonary function tests, respiratory muscle strength, 
SIPmax, 6-MWD, maximal exercise capacity, CRQ and TDI. However, respiratory 
muscle endurance capacity (HET), constant load exercise test (CLET) and 
perception of dyspnea at 80% iso-time during CLET (CLET BORG dyspnea) were 
significantly different between the groups in favour of the RMET-group (table 2). 
 
Respiratory muscle endurance capacity (HET), constant load exercise test (CLET) 
and 6-MWD increased significantly during the 12-week rehabilitation period in both 
groups, whereas maximal exercise capacity (Wmax CPET) and SIPmax only 
increased in the control group. Borg score for dyspnea at iso-time 80% of endurance 
exercise significantly decreased in the RMET group. (table 3) 
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Table 1. Baseline demographic characteristics (test 1) 
 RMET-group Control-group P value 
(between groups) 
N 18 18  
age (yrs) 54.4 (7.7) 57.0 (8.5) 0.35 
sex M/F 8/10 9/9 0.75 
Smoking 
(packyears) 
33.1 (21.8) 33.8 (16.2) 0.90 
BMI (kg/m2) 26.7 (5.0) 27.5 (3.3) 0.61 
FEV1 (litres) 1.5 (0.4) 1.7 (0.5) 0.15 
FEV1(%pred) 50 (14) 58 (15) 0.10 
FEV1/IVC 46 (13) 50 (14) 0.47 
RV (%pred) 137 (38) 127 (26) 0.36 
Pimax kpa 6.9 (2.9) 7.2 (2.3) 0.69 
Pimax (%pred) 89 (34) 93 (28) 0.73 
HET (minutesseconds) 854 (549) 629 (425) 0.17 
SIPmax (kpa) 2.5 (0.9) 2.9 (1.2) 0.37 
Wmax CPET (watt) 111 (33) 123 (35) 0.29 
Wmax (%pred) 
CPET 
65 (16) 67 (15) 0.66 
VO2peak ml/min/kg 19.6 (4.5) 19.3 (4.0) 0.85 
6-MWD (m) 519 (89) 550 (75) 0.27 
6-MWD (%pred) 92 (15) 100 (12) 0.09 
CLET 
(minutesseconds) 
1751 (1048) 1624 (1530) 0.75 
CLET BORG 
dyspnea 
8.4 (1.9) 8.3 (1.7) 0.78 
Data are expressed as means (SD) 
Legend to table 1: 
BMI=body mass index  
FEV1= forced expiratory volume in 1 second 
%pred=percentage of predicted value 
IVC=inspiratory vital capacity 
RV=residual volume 
Pimax=maximal inspiratory mouth pressure 
HET=hyperpnea endurance test 
SIPmax= maximal sustainable inspiratory mouth pressure 
Wmax CPET=maximal work load in watts during cardio-pulmonary exercise testing  
VO2peak ml/min/kg=peak oxygen uptake in millilitres per minute per kilogram 
6-MWD=6 minutes walking distance 
CLET=constant load exercise test on cycle ergometer 
CLET BORG dyspnea: Borg score for dyspnea during constant load exercise test at iso-time 
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Table 2: Demographics at start of rehabilitation (test 2) 
 RMET-group Control-group P value 
(between groups) 
Respiratory muscle 
function 
   
Pimax kpa 7.3 (2.8) 7.5 (3.0) 0.67 
Pimax (%pred) 94 (32) 95 (35) 0.94 
HET (minutesseconds) 1353 (548) 543 (419) <0.001 
SIPmax (kpa) 3.1 (1.4) 2.6 (1.2) 0.23 
Exercise performance    
Wmax CPET (watt) 120 (38) 126 (42) 0.64 
Wmax (%pred) CPET 70 (18) 71 (25) 0.87 
VO2peak ml/min/kg 19.9 (4.7) 19.9 (5.1) 0.97 
6-MWD (meters) 535 (77) 544 (85) 0.76 
CLET (minutesseconds) 2816 (1454) 1635 (1402) 0.02 
CLET BORG dyspnea 5.4 (1.3) 7.2 (2.2) 0.01 
Quality of life CRQ total 86.6 (18.4) 85.0 (15.0) 0.78 
Data are expressed as means (SD) 
 
Legend to table 2: 
Pimax=maximal inspiratory mouth pressure 
HET=hyperpnea endurance test 
SIPmax= maximal sustainable inspiratory mouth pressure 
Wmax CPET=maximal work load in watts during cardio-pulmonary exercise testing  
VO2peak ml/min/kg=peak oxygen uptake in millilitres per minute per kilogram 
6-MWD=6 minutes walking distance 
CLET=constant load exercise test on cycle ergometer 
CLET BORG dyspnea: Borg score for dyspnea during constant load exercise test at iso-time 
CRQ=Chronic Respiratory Disease Questionnaire 
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Table 3: Changes in respiratory muscle performance and exercise capacity 
 RMET Control P-Delta 
(between 
groups) 
 pre-rehab 
test 1-2 
rehab 
test 2-3 
pre-rehab
test 1-2 
rehab 
test 2-3 
test 1versus 3 
Wmax CPET(watt) +10(15)* +4(14) +2(13) +11(17)* 0.45 
VO2peak (ml/min) +52(115) +15(173) 17(260) +51(196) 0.55 
Pimax (kpa) +0.7(1.6) +1.0(1.6) +1.1(3.9) +1.1(1.0) 0.80 
Pemax (kpa) +0.8(3.8) -0.1(4.3) +2.3(4.6) +1.2(4.3) 0.48 
HET (minutesseconds) +459(332)‡ +230(311)† -046(133)* +200(235)† <0.001 
SIPmax (kpa) +0.6(0.8)* +0.4(0.9) -0.3(0.5) +0.5(0.7)* 0.02 
6-MWD (meters) +23(31)† +42(39)‡ -6(32) +32(31)‡ 0.02 
CLET (minutesseconds) +1024(639)‡ +519(1049)* +011(410) +715(836)* 0.03 
CLET BORG dyspnea -3.0(2.1)‡ -1.0(1.4)† -0.8(2.1) -0.8(2.7) 0.01 
Data are expressed as means (SD) 
* p≤0.05 before versus after testing (within group) 
† p≤0.01 before versus after testing (within group) 
‡ p≤0.001 before versus after testing (within group) 
 
Legend to table 3: 
Wmax CPET=maximal work load in watts during cardio-pulmonary exercise testing 
VO2peak ml/min=peak oxygen uptake in millilitres per minute 
Pimax=maximal inspiratory mouth pressure 
Pemax= maximal expiratory mouth pressure 
HET=hyperpnea endurance test 
SIPmax= maximal sustainable inspiratory mouth pressure 
6-MWD=6 minutes walking distance 
CLET=constant load exercise test on cycle ergometer 
CLET BORG dyspnea: Borg score for dyspnea during constant load exercise test at iso-time 
P-Delta: significance of training induced changes (post- minus pre-training values: 
delta) between groups by ANCOVA 
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The extent of improvement during the 12-week rehabilitation-period (test 2 versus 3) 
did not significantly differ between both groups. However, the improvement over the 
whole study period (test 1 versus 3) was significantly higher in the RMET-group than 
in the control-group with respect to constant load exercise test, 6-MWD, HET, 
SIPmax and perception of dyspnea as measured by CLET BORG dyspnea. (figure 2, 
table 3) 
 
Both groups showed a significant improvement in the CRQ, i.e. the total score and all 
domains separately improved, as well as dyspnea during daily activities (TDI). 
Improvements in CRQ and TDI during the 12-week rehabilitation period were not 
statistically significant between the groups. (table 4) 
 
Table 4: Changes in health-related quality of life and dyspnea: CRQ and TDI 
 RMET Control P-Delta 
(between groups) 
 pre-rehab 
test 1-2 
rehab 
test 2-3 
pre-rehab 
test 1-2 
rehab 
test 2-3 
test 1 versus 3 
CRQ total score +7.9(8.8)‡ + 18.4(13.8)‡ +2.6(8.5) + 18.6(11.8)‡ 0.67 
CRQ dyspnea +2.8(3.9)† + 4.9(3.6)‡ +0.3(2.1) + 5.8(5.2)‡ 0.84 
CRQ mastery +2.0(1.8)‡ + 3.2(2.5)‡ +0.8(3.1) + 3.7(3.4)‡ 0.96 
CRQ emotional +1.4(3.9) + 5.9(6.1)‡ +0.8(2.3) + 4.4(3.1)‡ 0.38 
CRQ fatigue +1.7(3.1)* + 4.4(4.0)‡ +0.7(3.1) + 4.7(3.3)‡ 0.91 
Dyspnea TDI +2.8(2.5) + 2.2(2.0) -0.2(1.6) +4.0(3.3) 0.39 
Data are expressed as means (SD) 
* p≤0.05 before versus after testing (within group) 
† p≤0.01 before versus after testing (within group) 
‡ p≤0.001 before versus after testing (within group) 
 
CRQ=Chronic Respiratory Disease Questionnaire 
TDI=Transition Dyspnea Index 
P-Delta: significance of training induced changes (post- minus pre-training values: 
delta) between groups by ANCOVA 
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Figure 2: schematic view of changes over time with respect to HET and CLET  
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DISCUSSION 
The results of this study in patients with moderate to severe COPD indicate that 
priming of the respiratory muscles by means of RMET before pulmonary 
rehabilitation leads to a significantly better outcome of a pulmonary rehabilitation 
program with regard to endurance exercise capacity, respiratory muscle endurance 
capacity and perception of dyspnea during exercise. No significant differences were 
found with respect to improvements in quality of life and in dyspnea during daily 
activities.  
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To our knowledge this is the first study showing that priming of the respiratory 
muscles before pulmonary rehabilitation leads to a better outcome of this program. 
So far some reports have been published on the effects of adding respiratory muscle 
training during a pulmonary rehabilitation program. These studies generally used 
strength training by means of inspiratory resistive training or threshold loading,4-6 
instead of endurance training, and showed results that considerably vary, i.e. from 
improvement of maximal exercise performance5 and 12-minute walking distance,4 to 
no effect on maximal and endurance exercise performance.6 Only two studies have 
applied endurance respiratory muscle training by means of normocapnic hyperpnea 
during pulmonary rehabilitation in patients with COPD.2;3  We found a statistically 
significant difference in improvement for endurance exercise capacity (CLET: +88%) 
and functional exercise capacity (6-MWD: +13%) between our study group and the 
control group, whereas Levine and co-workers did not show a significant difference in 
improvement between their study group and the control group for these parameters. 
In their COPD patients with an FEV1 of about 1.5 litre the placebo training consisted 
of intermittent positive pressure ventilation during only one hour a day.2 The second 
study that applied normocapnic hyperpnea in patients with COPD (FEV1 1 litre) even 
found no statistically significant increase in the 12-Minute-walking-distance within the 
study group. The improvement of 65 meters in our study is not only statistically 
significant but also clinically relevant.20 The difference in outcome likely results from 
the training protocol because the above mentioned studies started respiratory muscle 
training and general exercise training at the same time. Hence, the ventilatory 
muscles were not physiologically optimized before the start of the pulmonary 
rehabilitation. In summary, our study shows that RMET by means of tube-breathing 
applied before and during pulmonary rehabilitation, leads to an improvement in sub-
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maximal endurance exercise capacity, which is a sensitive and valid method to asses 
changes in endurance exercise capacity.23;24  
 
Notwithstanding the beneficial effects on endurance exercise capacity and dyspnea, 
priming of the respiratory muscles by means of RMET had no additional effects on 
quality of life and dyspnea during daily activities. Both increased significantly and 
clinically relevant within the RMET-group as well as the control-group, yet without a 
significant difference between the groups.  
 
One of the limitations of our study is the fact that only patients with moderate and 
severe COPD were included. Especially patients with very severe COPD often have 
impaired respiratory muscle performance and/or a ventilatory limitation during 
exercise. Moreover, these patients often are eligible for participation in a pulmonary 
rehabilitation program. Given the positive effects of RMET before starting a 
rehabilitation program, we believe it of prime importance to further investigate this 
rehabilitation extension in patients with more severe COPD. However, RMET may be 
very hard to perform for this group of patients because their inspiratory capacity is 
often reduced as a result of (severe) hyperinflation. 
 
As a result of our design, the time schedule of our study can be divided into two 
separate periods. The first period consists of home-based RMET before the start of 
rehabilitation (between test 1 and 2) These results have been described elsewhere. 
The second period, as described in this paper, covers the 12-week rehabilitation 
period (between test 2 and 3). At baseline (test 1, table 1) there were no differences 
between the two groups. However, after 5 weeks of home-based RMET, significant 
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differences had already occurred between both groups for respiratory muscle 
endurance, exercise endurance and perception of dyspnea (test 2, see table 2). In 
the ensuing 12 weeks of pulmonary rehabilitation, the extent of change that was 
achieved, with respect to respiratory and exercise endurance capacity and quality of 
life and dyspnea, did not differ significantly between both groups (table 3 and table 
4). These observations are schematically reflected in figure 2 and have two major 
implications. First, home based RMET could partially replace rehabilitation, especially 
when the primary goal is to improve sub-maximal endurance exercise capacity. 
Secondly, priming of the respiratory muscles before the start of pulmonary 
rehabilitation leads to a better outcome of this program, because patients have a 
better starting-point after home-based RMET, which is not catched up by the control 
group after 12 weeks of rehabilitation.  
 
The improvement in exercise capacity in our COPD patients can, in part, be 
explained by the improved respiratory muscle function.25 HET and SIPmax 
significantly improved in our study group. In accordance with our results, previous 
studies using endurance respiratory muscle training as a training mode in patients 
with COPD also showed improvements in respiratory muscle function.2;7;26 
Adaptation to dyspnea, which originates in the central nervous system because of an 
imbalance between the motor neural output to the respiratory muscles and the 
magnitude of ventilation resulting from it, may be another explanation for the 
improved exercise capacity. During RMET, patients were enforced to increase their 
motor neural output daily, which may have led to an adaptation to this higher output, 
and thus a reduction in dyspnea. However, our study was not designed to answer 
this question. Nevertheless, our results show that an improved respiratory muscle 
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function leads to an increased exercise capacity. Whether adaptation to dyspnea 
sensation plays an important role in improvements in exercise capacity, needs further 
study. 
 
The results of this study may have important clinical implications. Respiratory muscle 
training previously has been recommended as part of a pulmonary rehabilitation 
program, only in selected patients with decreased respiratory muscle strength and 
breathlessness.1 Patients in our study were not selected because of respiratory 
muscle weakness or ventilatory limitation. Analysis of our data showed only a slightly 
lower Pimax compared to reference values.14 Therefore, optimizing the respiratory 
muscles with endurance respiratory muscle training before the start of a pulmonary 
rehabilitation program, should be considered for all COPD patients, even those 
without impaired respiratory muscle function and it leads to a better outcome of a 
rehabilitation program.  
 
In summary, we have shown that, optimizing the respiratory muscles by means of 
Respiratory Muscle Endurance Training in patients with moderate to severe COPD 
leads to a better outcome of a pulmonary rehabilitation program in terms of 
endurance exercise capacity, respiratory muscle performance and dyspnea 
perception during exercise. Many rehabilitation clinics have waiting lists up to several 
weeks before patients can be admitted. This study shows that such a period can be 
gainfully used by optimizing the respiratory muscles with home-based RMET by 
means of tube-breathing. This even results in a better outcome of the rehabilitation 
program. 
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SUMMARY 
Chronic Obstructive Pulmonary Disease (COPD) is characterised by chronic airflow 
limitation that is not fully reversible. This airflow limitation is usually progressive and 
associated with an abnormal inflammatory response of the lungs to noxious particles 
or gases. Smoking cessation is the first step in the treatment of this disease. 
Inhalation therapy with bronchodilators is the most important pharmacological 
intervention to symptom management in COPD. Non-pharmacologic treatment 
includes rehabilitation, respiratory muscle training, ventilatory support, oxygen 
therapy and surgical interventions.  
The studies presented in this thesis focussed on the effects of Respiratory Muscle 
Endurance Training (RMET), by means of normocapnic hyperventilation, in patients 
with COPD. Several reports have shown that RMET has beneficial effects, especially 
on endurance exercise performance in healthy volunteers, athletes and patients with 
COPD. However, the equipment used to remain normocapnic during a period of 
hyperpnea is very complicated and expensive, and therefore not available to a large 
population. The aim of this thesis was to asses whether RMET by means of tube-
breathing, which is very easy and inexpensive, would be safe and feasible, and 
whether it would have beneficial effects on endurance exercise capacity, health-
related quality of life and dyspnea in patients with moderate to severe COPD. 
Furthermore we wanted to test whether optimising the respiratory muscles of COPD 
patients before the start of a rehabilitation program, would lead to a better outcome of 
this program.  
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Chapter 1 
Chapter 1 gives a survey of the various types of respiratory muscle training. Based 
on the physiologic principles of strength- and endurance-training two different 
methods of respiratory muscle training can be distinguished: strength-training by 
means of inspiratory resistive training and threshold loading versus endurance 
training based on normocapnic hyperpnea, which is also known as Respiratory 
Muscle Endurance Training (RMET). The effects of these training regimens on 
different outcome parameters, such as respiratory muscle performance, maximal and 
endurance exercise capacity, health-related quality of life and dyspnea are 
discussed. Furthermore the objectives of the studies are outlined.  
 
Chapter 2 
In this study we evaluated the feasibility and safety of Respiratory Muscle Endurance 
Training by means of tube-breathing in healthy volunteers. RMET is based on the 
principle of normocapnic hyperpnea. This technique is not applied on a large scale 
because complicated and expensive equipment is needed to maintain CO2 
homeostasis during hyperpnea. This CO2 homeostasis can be preserved during a 
period of hyperpnea by enlarging the dead space of the ventilatory system. One of 
the possibilities to do so is to breathe through a tube. Thus, RMET by means of tube-
breathing might be a new and inexpensive method to perform respiratory muscle 
training, possibly in a home-based setting. However, the safety (hypoxemia) and the 
effects of this kind of tube breathing on CO2 homeostasis have never been 
evaluated. Therefore we performed a 10-minute run of tube-breathing in 20 healthy 
volunteers. The dead space of the ventilatory system was enlarged with 60% of the 
individuals Forced Vital Capacity. We measured oxygenation and PaCO2. We also 
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determined perception of dyspnea (Borg-scores), respiratory muscle function and 
hypercapnic ventilatory responses. 14 out of 20 subjects became hypercapnic during 
tube breathing (PaCO2>6.0 Kpa). No significant correlations were found between the 
different parameters. Subsequently, subjects were divided into two groups: 
normocapnic versus hypercapnic and mean values were compared. No significant 
differences were observed for change in oxygen saturation measured by oximetry 
(normocapnic –0.7% versus hypercapnic –0.2%, p=0.6), Borg score (normocapnic 
4.3 versus hypercapnic 4.7, p=0.9) , respiratory muscle function nor hypercapnic 
ventilatory responses. Clinically relevant desaturations did not occur. We therefore 
concluded that tube breathing is well tolerated amongst healthy subjects. It may lead 
to hypercapnia, but seems a safe and feasible method in healthy subjects. When 
tube-breathing will be applied as respiratory muscle training modality, especially in 
patients with COPD, the potential development of hypercapnia must be considered. 
 
Chapter 3 
Chapter 3 describes the effects of tube breathing on CO2 homeostasis in COPD 
patients. The function of respiratory muscles can improve in response to training. 
Home-based endurance respiratory muscle training by means of tube-breathing is 
possibly a new training modality for respiratory muscles. The aim of this study was to 
investigate the effect of this tube-breathing on CO2 homeostasis in patients with 
chronic obstructive pulmonary disease (COPD). We hypothesized that the ventilatory 
control system will stimulate ventilation during tube breathing, in order to preserve 
normocapnia. 
Fourteen consecutive patients with moderate and severe COPD were included in the 
study. Pulmonary function test, hypercapnic ventilatory responses, endurance 
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capacity of the respiratory muscles and tube-breathing with dyspnea scores (Borg) 
were performed.  
Strikingly, four patients became hypercapnic (PaCO2>6.0 kpa) during tube-breathing. 
These hypercapnic patients had significantly more severe COPD, more 
hyperinflation, a worse capacity of their respiratory muscles and more dyspnea 
during tube-breathing compared to the normocapnic patients. No significant 
difference was found for the hypercapnic ventilatory response. 
This study shows that impaired respiratory muscle capacity leads to hypercapnia and 
more dyspnea during tube-breathing in patients with moderate and severe COPD, 
whereas the ventilatory controlling system does not seem to play an important role. 
 
Chapter 4 
The effects of home-based RMET, by means of tube breathing, on endurance 
exercise capacity are described in this chapter. The aim of this study was to asses 
whether RMET improves exercise capacity and perception-of-dyspnea in patients 
with chronic obstructive pulmonary disease (COPD). We therefore randomised 36 
patients with moderate to severe COPD to RMET (n=18) by means of tube-breathing 
or to sham training (control: n=18). Both groups trained twice daily for 15 minutes, 7 
days per week, during 5 weeks. Endurance exercise performance on a cycle-
ergometer showed a significant increase in the RMET-group: 1071±648 to 1696±894 
seconds (mean±SD), p<0.001. 6-minutes-walking-distance and maximal exercise 
capacity also increased; 512±86 to 535±77 meters, p=0.007, and 111±33 to 120±38 
watt, p=0.02 respectively. Perception-of-dyspnea (Borg-score) decreased from 
8.4±1.9 to 5.4±1.3, p<0.001. Respiratory muscle endurance capacity also increased 
in the RMET-group: hyperpnea-endurance-time and sustainable inspiratory pressure 
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increased from 534±349 to 833±348 seconds, p<0.001 and from 2.5±0.9 to 3.1±1.4 
kpa, p=0.005 respectively. The control-group showed no significant changes.  
Ventilatory parameters were also analysed during the constant-load exercise test on 
a cycle ergometer at iso-time. This provides effort-independent information regarding 
training effects. In the RMET group, minute ventilation at iso-time (80% of the first 
test) decreased from 43 to 40 litres, p=0.03, respiratory rate decreased from 37 to 30 
breaths/minute, p<0.001, tidal volume increased from 1.2 to 1.4 litres, p=0.04 and 
BORG-score decreased from 8 to 5, p<0.001. The control-group showed no 
significant changes. In conclusion, home-based RMET by means of tube-breathing 
leads to an improvement of endurance exercise capacity, a reduction in perception-
of-dyspnea, and an improvement of respiratory muscle performance in patients with 
moderate to severe COPD. 
 
Chapter 5 
Not only physiologic parameters in terms of exercise capacity are important in the 
evaluation of COPD patients. Parameters as dyspnea and health status are at least 
as important. In this chapter we described the effects of home-based RMET on 
dyspnea and health-related quality of life in the same study subjects as described in 
the previous chapter. 36 patients with COPD, GOLD II and III were randomised into 
two groups: RMET by means of tube-breathing (n=18) and sham training with an 
incentive spirometer (control: n=18). Patients in both groups trained twice daily, 15 
minutes, 7 days a week during 5 weeks. Pulmonary function tests and respiratory 
muscle performance was measured. Dyspnea scores were determined by means of 
Mahler’s Baseline Dyspnea Index and Transition Dyspnea Index (BDI and TDI). 
Health status was evaluated by the Chronic Respiratory Disease Questionnaire 
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(CRQ). Patients in the RMET-group showed significant improvement of respiratory 
muscle endurance capacity. There was also a significant improvement in dyspnea 
and quality of life in the RMET-group: TDI-focal score increased by 2.8±2.5 points 
[mean±SD], p=0.001, CRQ-total score increased from 78.7±20.6 to 86.6±18.4, 
p=0.001. The control group showed no significant changes. These data confirm the 
hypothesis that RMET by means of tube-breathing leads to a reduction in dyspnea 
and an improvement in quality of life. Furthermore, RMET can interrupt a negative 
loop that originates in many patients with COPD. Respiratory muscle deconditioning 
contributes to dyspnea, which influences quality of life and mastery in a negative 
way. Dyspnea itself, leads to a decrease in physical activities, which acts negatively 
upon quality of life. A decline in physical activity leads to further deconditioning of the 
organism as a whole and the respiratory muscles in detail. Both aspects lead to a 
further decline in health status.  
The results of chapter 4 and chapter 5 might have implications for the future non-
pharmacologic management of moderate and severe COPD patients. With the 
knowledge that RMET by means of tube breathing is not very expensive and easy 
applicable, and therefore available to almost all chest physicians, it can be 
speculated that this mode of ventilatory muscle training should not be reserved for 
combination along with a pulmonary rehabilitation program. RMET might even, in 
part, replace pulmonary rehabilitation when this form of therapy is not available. 
 
Chapter 6 
In this chapter we describe the effects of Respiratory Muscle Endurance Training on 
the outcomes of a pulmonary rehabilitation program. Respiratory Muscle Endurance 
Training leads to an improvement of exercise capacity and to a reduction in the 
 135
Chapter 7 
perception of dyspnea. We therefore hypothesized, that optimizing the condition of 
the respiratory muscles by means of RMET, before the start of a rehabilitation 
program might lead to a better outcome of such a program. Endurance exercise 
capacity and perception of dyspnea were primary outcome parameters. We also 
looked at the effects of this intervention on quality of life and dyspnea during daily 
activities. The same patients as described in chapter 4 and chapter 5 continued after 
5 weeks of home-based training with either RMET or sham training, during the 
subsequent rehabilitation program. Patients had moderate and severe COPD and 
they had already (randomly) been divided into Respiratory Muscle Endurance 
Training (RMET: n=18) by means of tube-breathing or to sham training (control: 
n=18) with an incentive flowmeter. As was mentioned before, both groups trained two 
times a day for 15 minutes, during 17 weeks. Training started 5 weeks prior to the 
start of pulmonary rehabilitation and was continued until the end of the rehabilitation 
program. During rehabilitation, improvements in respiratory muscle endurance 
capacity and exercise endurance performance were not statistically different between 
both groups. Quality of life and dyspnea during daily activities also improved to the 
same, statistically and clinical relevant, extent. However, due to the 5 weeks of 
isolated home-based RMET, patients in the RMET-group achieved significantly better 
improvements during the entire training-period (preceding home-based RMET and 
subsequent pulmonary rehabilitation) as compared to the control group for the 
following variables: Respiratory muscle endurance capacity, p<0.001; endurance 
exercise capacity, p=0.03 (see figure 1) and perception of dyspnea (Borg-score), 
p=0.01. We therefore concluded that RMET by means of tube-breathing leads to a 
better outcome of a pulmonary rehabilitation program in terms of respiratory muscle 
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performance and exercise endurance capacity with less dyspnea in patients with 
moderate and severe COPD. 
 
Figure 1:  schematic view of changes over time with respect to respiratory 
muscle endurance capacity and exercise endurance capacity  
 
Respiratory muscle and  
Exercise endurance 
capacity 
 
 
 
           RMET 
 
 
                 P<0.05 
 
 
                 control/sham 
            
 
           p<0.05 
 
 
 
 
 
test1          test 2              test 3 
(baseline) 
 
 
start training   start rehabilitation/    end rehabilitation/ 
(RMET or sham)   continue training    end training 
 
 
 137
Chapter 7 
GENERAL DISCUSSION 
Respiratory muscle training has been applied since several decades in order to 
improve not only respiratory muscle function, but also exercise capacity. This 
respiratory muscle training was mostly performed by means of inspiratory resistive 
training and threshold loading. These training modalities are mainly based on the 
physiological principals of strength training. Inspiratory manoeuvres against a 
resistance are performed with low frequencies and high power. The studies 
performed with this respiratory muscle strength training, showed improvements in 
respiratory muscle function. However, the results with regard to exercise capacity 
showed some inconsistencies. This may partly be due to the different training 
frequencies and intensities, different duration of training and different patient 
selection that was used. Furthermore some studies applied this training in 
conjunction with general exercise training, which is an important part of a pulmonary 
rehabilitation program. This led to the recommendation that respiratory muscle 
training can be applied as part of a pulmonary rehabilitation program, only for 
selected patients with decreased respiratory muscle strength and breathlessness.1  
Literature from sports medicine,2;3 healthy sedentary subjects4;5 and patients with 
COPD6 and cystic fibrosis4 shows that respiratory muscle training that is mainly 
based on endurance principles is a very promising technique, because it leads to 
improvement in ventilatory muscle endurance capacity and endurance exercise 
capacity. In this kind of respiratory muscle endurance training subjects perform 
unloaded breathing with high frequencies and large tidal volumes. This method of 
respiratory muscle training is based on normocapnic hyperpnea. From a 
physiological point of view, this type of training is much closer related to daily life 
situations, which means that this endurance training is much more specific when 
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compared to strength training. Only one study looked at the effects of home-based 
RMET in patients with COPD.7 A complicated and very expensive device was used 
for home-based training. This study showed improvements in respiratory muscle 
endurance capacity, 6-MWD and Vo2-peak. However, no difference was found 
between the study group and the control group, in endurance exercise capacity and 
dyspnea during daily activities.  
In view of the above mentioned, we investigated whether home-based RMET could 
be performed by tube-breathing, which is easy to perform and inexpensive and 
therefore available to many patients. We have shown that that tube breathing is a 
safe and simple method to perform RMET. Furthermore in our studies RMET led to 
improvement in respiratory muscle endurance capacity, improvement in endurance 
exercise performance and reduction in dyspnea on exertion. Moreover dyspnea 
during daily activities improved, as well as health related quality of life. We also 
looked at effects of training and optimizing the respiratory muscles by means of 
RMET via tube-breathing before the start of a pulmonary rehabilitation program. In 
the RMET group, endurance exercise capacity, respiratory muscle endurance 
capacity as well as perception of dyspnea showed a significant better improvement 
during this period as compared to a control group. No difference was found for 
dyspnea and quality of life.  
 
In view of the above mentioned it can be concluded that respiratory muscles can be 
trained in several ways. Strength training and endurance training have been 
investigated since several decades. However, endurance training did not gain much 
interest for clinical use because it involved practical problems in terms of expensive 
and complicated equipment. This led to a decreased interest for this technique and 
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consequently less clinical studies. On the other hand commercially available 
threshold loaders and incentive spirometers for respiratory muscle strength training 
were developed. Since then a lot of studies have been performed with these devices 
and they are widely used in daily practice. However, when looking at daily-life 
situations and at the specificity of training, endurance respiratory muscle training may 
be much better. The results with this technique are promising and with new 
equipment, that enables home-based training, more studies can be performed and 
routine clinical use becomes available. 
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SAMENVATTING 
Chronisch Obstructief Longlijden (COPD) wordt gekenmerkt door een chronische 
luchtwegvernauwing welke niet volledig reversibel is. Deze luchtwegvernauwing is 
meestal progressief en gaat gepaard met een abnormale inflammatoire reactie van 
de luchtwegen en longen, op giftige deeltjes of gassen. De eerste stap in de 
behandeling van COPD betreft het stoppen met roken. Inhalatie therapie met 
luchtwegverwijders is de belangrijkste farmacologische interventie, met name gericht 
op symptoombestrijding. Non-farmacologische behandelingen bestaan uit 
longrevalidatie, ademspiertraining, non-invasieve ademhalingsondersteuning, 
zuurstoftoediening en chirurgische interventies.  
De studies in dit proefschrift beschrijven de effecten van ademspier-duurtraining 
(Respiratory Muscle Endurance Training; RMET), door middel van normocapnische 
hyperpnoe, bij patiënten met COPD. Meerdere publicaties hebben laten zien dat 
RMET gunstige effecten heeft, met name op het inspannings-duurvermogen, bij 
gezonde vrijwilligers, atleten en patiënten met COPD. Echter de apparatuur, die 
noodzakelijk is om tijdens een periode van hyperpnoe, normocapnisch te blijven, is 
erg duur en gecompliceerd. Dientengevolge is deze trainingsmethode niet voor een 
grote populatie beschikbaar. Het doel van dit proefschrift was te onderzoeken of 
ademspier-duurtraining op een veilige manier verricht kan worden door middel van 
het ademen met een opgelegde frequentie, door een slangensysteem, waardoor de 
dode ruimte fors vergroot wordt: tube-breathing. Voorts werd onderzocht of tube-
breathing gunstige effecten heeft op het inspannings-duurvermogen, op dyspnoe en 
op de kwaliteit van leven bij patiënten met matig en ernstig COPD. Bovendien werd 
onderzocht of het optimaliseren van de ademspieren, voorafgaand aan een 
longrevalidatie programma, leidt tot een betere uitkomst van een dergelijk 
 142
Samenvatting en discussie 
programma. Hierbij dient opgemerkt te worden dat tube-breathing een eenvoudige 
en goedkope trainingsmethode is .  
 
Hoofdstuk 1 
Hoofdstuk 1 geeft een overzicht van de verschillende methoden van 
ademspiertraining. Twee verschillende vormen van ademspiertraining kunnen 
onderscheiden worden op basis van fysiologische trainingsprincipes: enerzijds 
kracht-training door middel van inspiratoire weerstandstraining en threshold loading, 
anderzijds duur-training door middel van normocapnische hyperpnoe. Deze laatste 
techniek wordt ook wel ‘respiratory muscle endurance training’ (RMET) genoemd. De 
effecten van bovengenoemde trainingsmodaliteiten op verschillende 
uitkomstparameters, zoals ademspierfunctie, maximaal- en duur-
inspanningsvermogen, kwaliteit van leven en dyspnoe worden besproken. Bovendien 
worden de studiedoelen besproken. 
 
Hoofdstuk 2 
In hoofdstuk 2 wordt de haalbaarheid en de veiligheid (ten aanzien van hypoxie) van 
RMET door middel van tube-breathing bij gezonde vrijwilligers beschreven. RMET is 
gebaseerd op het principe van normocapnische hyperpnoe. Normocapnische 
hyperpnoe wordt niet op grote schaal toegepast omdat gecompliceerde en dure 
apparatuur nodig is om CO2-homeostase te behouden tijdens een periode van 
hyperpnoe. Deze CO2-homeostase kan bewerkstelligd worden door de dode ruimte 
van het respiratoire systeem te vergroten. Een van de mogelijkheden om dat te doen 
is door middel van het ademen via de grote dode ruimte van een slangensysteem: 
tube-breathing. RMET door middel van tube-breathing zou een nieuwe en goedkope 
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manier kunnen zijn om ademspiertraining toe te passen, eventueel zelfs in de 
thuissituatie. Echter de veiligheid en de effecten van deze manier van tube-breathing 
op CO2-homeostase zijn nooit onderzocht.  
Derhalve verrichtten 20 gezonde vrijwilligers een 10 minuten durende tube-breathing 
sessie. De dode ruimte van het ventilatoire systeem werd met 60% van de 
individuele geforceerde vitale capaciteit vergroot. Oxygenatie en koolzuurspanning 
werden bepaald, evenals dyspnoe perceptie (Borg-score), ademspierfunctie en de 
hypercapnische ventilatoire respons. Bij 14 van de 20 vrijwilligers ontstond 
hypercapnie tijdens tube-breathing (PaCO2>6,0 Kpa). Er werden geen significante 
correlaties gevonden tussen de verschillende parameters. Vervolgens werden de 
proefpersonen op grond van hun CO2 gehalte verdeeld in twee groepen: 
normocapnisch versus hypercapnisch, waarbij de gemiddelde waardes vergeleken 
werden. Er werden geen significante verschillen gevonden ten aanzien van: 
verandering in oxygenatie, gemeten door middel van oxymetrie (normocapnisch –
0,7% versus hypercapnisch –0,2%, p=0,6), Borg-score (normocapnisch 4,3 versus 
hypercapnisch 4,7, p=0,9), ademspierfunctie of hypercapnische ventilatoire respons. 
Er traden geen klinisch relevante desaturaties op. Deze studie laat zien dat RMET 
door middel van tube-breathing kan leiden tot hypercapnie, echter het wordt goed 
verdragen en leidt niet tot significante bijwerkingen. Derhalve lijkt RMET een veilige 
en haalbare methode voor ademspiertraining bij gezonde personen. 
 
Hoofdstuk 3 
In dit hoofdstuk worden de effecten van tube-breathing op CO2-homeostase, bij 
patiënten met COPD, beschreven. De functie van de ademhalingsspieren kan 
verbeteren ten gevolge van training. RMET door middel van tube-breathing, 
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toegepast in de thuissituatie zou een nieuwe trainingsmodaliteit voor de 
ademhalingsspieren kunnen zijn.  
Het doel van deze studie was te onderzoeken wat het effect van tube-breathing op 
CO2-homeostase is bij patiënten met COPD. De hypothese luidde dat het 
respiratoire regelmechanisme de ademhaling zodanig zou stimuleren tijdens tube-
breathing, dat normocapnie zou blijven bestaan. Veertien opeenvolgende patiënten 
met matig en ernstig COPD werden geincludeerd in de studie. Patiënten 
ondergingen longfunctie testen, een hypercapnische ventilatoire respons, een 
ademspierduurtest en een tube-breathing sessie met dyspnoe-score (Borg). Tijdens 
tube-breathing werden 4 patiënten hypercapnisch (PaCO2>6,0 kpa). Deze 
hypercapnische patiënten hadden een significant ernstiger COPD, meer 
hyperinflatie, een slechtere ademspierfunctie en hogere dyspnoe scores tijdens tube-
breathing in vergelijking met de normocapnische patiënten. Er werd geen significant 
verschil gevonden ten aanzien van de hypercapnische ventilatoire respons. Ook 
werd geen klinisch relevante desaturatie gevonden bij deze COPD-patienten tijdens 
tube-breathing. 
Deze studie toont dat met name een verminderde ademspierfunctie leidt tot 
hypercapnie en meer dyspnoe tijdens tube-breathing in patiënten met matig en 
ernstig COPD. Het respiratoire regelmechanisme lijkt geen belangrijke rol te spelen 
in deze.  
 
Hoofdstuk 4 
In dit hoofdstuk worden de effecten van RMET, door middel van tube-breathing, op 
het inspannings-duurvermogen beschreven. Het doel van deze studie was te 
onderzoeken of RMET leidt tot een verbetering van het inspanningsvermogen en een 
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afname van dyspnoe-sensaties bij patiënten met matig en ernstig COPD. Hiertoe 
werden 36 patiënten gerandomiseerd in twee groepen: RMET door middel van tube-
breathing in de thuissituatie (n=18) of placebo-training (controle n=18). Beide 
groepen trainden twee maal daags gedurende 15 minuten, 7 dagen per week 
gedurende 5 weken. Het inspannings-duurvermogen, dat gemeten werd op een 
fietsergometer op 50% van het individueel behaalde maximale wattage, toonde een 
significante toename in de RMET-groep: van 17 minuten 51 seconden naar 28 
minuten en 16 seconden, p<0,001. De 6-minuten loopafstand en het maximale 
inspanningsvermogen namen ook toe: van 512 naar 535 meter, p=0,007 en van 111 
naar 120 watt, p=0,02 respectievelijk. De dyspnoe-sensatie (Borg-score) nam af van 
8,4 naar 5,4, p<0,001. Ook het ademspier-duurvermogen verbeterde in de RMET-
groep. Hyperpnoe-endurance-time nam toe van 534 naar 833 seconden, p<0,001 en 
sustainable inspiratory pressure nam toe van 2,5 naar 3,1 kpa, p=0,005. De controle-
groep toonde geen significante veranderingen.  
Behalve bovengenoemde uitkomsten werden ook ventilatoire parameters op gelijke 
tijdstippen tijdens de inspanningduurtest vergeleken tussen de eerste en de tweede 
test: iso-time vergelijking. Parameters werden vergeleken op 80% van de tijd welke 
behaald was bij de eerste inspanningsduurtest. Een dergelijke vergelijking geeft 
inspanningsonafhankelijke informatie met betrekking tot eventueel behaalde 
trainingseffecten. In de RMET-groep daalde het ademminuut volume van 43 naar 40 
liter, p=0.03. De ademhalingsfrequentie daalde van 37 naar 30 teugen per minuut, 
p<0,001 en het teugvolume steeg van 1,2 naar 1,4 liter, p=0,04. De Borg-score 
daalde van 8 naar 5, p<0,001. De controle groep toonde geen significante 
verschillen. Derhalve werd geconcludeerd dat RMET door middel van tube-breathing 
leidt tot een verbetering van het inspanningsduurvermogen, een afname van 
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dyspnoe sensatie en een verbetering van de ademspierfunctie bij patiënten met 
matig en ernstig COPD. 
 
Hoofdstuk 5 
Bij het evalueren van COPD patiënten zijn niet alleen fysiologische parameters van 
belang. Steeds meer belang wordt gehecht aan parameters als dyspnoe en kwaliteit 
van leven. In dit hoofdstuk worden de effecten van RMET op dyspnoe en kwaliteit 
van leven beschreven in dezelfde populatie als beschreven in het vorige hoofdstuk. 
36 patiënten met matig en ernstig COPD werden gerandomiseerd over twee 
groepen: RMET door middel van tube-breathing (n=18) en placebo-training met een 
incentive spirometer (controle n=18). Alle patiënten trainden twee maal daags 
gedurende 15 minuten, 7 dagen per week gedurende 5 weken. Longfunctie 
onderzoek en ademspiertesten werden verricht. Dyspnoe werd gemeten met behulp 
van Mahler’s Baseline Dyspnea Index en Transition Dyspnea Index (BDI en TDI). 
Kwaliteit van leven werd gemeten door middel van de Chronic Respiratory Disease 
Questionnaire (CRQ). Patiënten in de RMET-groep toonden een significante 
verbetering van het ademspier-duurvermogen. Ook dyspnoe en kwaliteit van leven 
verbeterden significant in de RMET-groep: TDI toonde een toename van 2,8 punten, 
p=0,001 en CRQ nam toe van 78,7 naar 86,6, p=0,001. De controle groep toonde 
geen significante veranderingen. Deze data bevestigen de hypothese dat RMET door 
middel van tube-breathing leidt tot een afname van dyspnoe en een verbetering van 
de kwaliteit van leven. Bovendien blijkt dat RMET de neerwaartse spiraal met 
betrekking tot verslechtering van dyspnoe en kwaliteit van leven, die bij vele 
patiënten met COPD ontstaat, kan doorbreken. Deconditionering van de 
ademhalingsspieren draagt bij aan dyspnoe, hetgeen de kwaliteit van leven negatief 
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beïnvloedt. Dyspnoe leidt tot een afname van fysieke activiteiten, hetgeen ook weer 
negatief werkt op kwaliteit van leven. Een afname van fysieke activiteiten leidt tot een 
verdere deconditionering van het gehele organisme, en daarmee gepaard gaande 
een verdere achteruitgang van de respiratoire spieren. Beide aspecten leiden tot een 
verslechtering van de kwaliteit van leven. 
De resultaten van hoofdstuk 4 en 5 zouden consequenties kunnen hebben voor de 
niet-farmacologische behandeling van patiënten met matig en ernstig COPD. Met de 
wetenschap dat RMET door middel van tube-breathing een goedkope en makkelijk 
toepasbare trainingsmethodiek is, kan gespeculeerd worden over de plaatsbepaling 
in de behandeling van COPD. Men zou kunnen stellen dat deze trainingsvorm, die op 
deze manier voor bijna iedereen beschikbaar is, niet alleen gereserveerd zou moeten 
worden voor toepassing in een revalidatieprogramma. RMET zou zelfs, indien 
revalidatie of inspanningstraining niet beschikbaar is, een goed alternatief kunnen 
zijn. 
 
Hoofdstuk 6 
In dit hoofdstuk worden de effecten van RMET op de uitkomsten van een revalidatie 
programma beschreven. RMET leidt tot een verbetering van het 
inspanningsvermogen en tot een afname van dyspnoe sensatie. Derhalve werd de 
volgende hypothese opgesteld: het optimaliseren van de ademhalingsspieren door 
middel van RMET, vóór de start van een revalidatie programma, leidt tot een betere 
uitkomst van een dergelijk programma. Primaire uitkomst parameters waren 
inspannings-duur-vermogen en dyspnoe sensatie. De effecten van deze interventie 
op kwaliteit van leven en dyspnoe tijdens activiteiten van het dagelijks leven werden 
ook gemeten. De patiënten, beschreven in hoofdstuk 4 en 5, starten na 5 weken 
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thuistraining met het revalidatie programma. Tijdens deze revalidatie periode 
continueerden zij hun eigen ademspiertraining (hetzij RMET, hetzij placebo-training). 
De patiënten hadden matig tot ernstig COPD, en zij waren reeds (at random) 
verdeeld in 2 groepen: Respiratory Muscle Endurance Training (RMET: n=18) door 
middel van tube-breathing of placebo training (controle: n=18) met een incentive 
flowmeter. Beide groepen trainden 2 maal per dag 15 minuten, gedurende 17 weken. 
De ademspiertraining startte 5 weken voor de start van de longrevalidatie en werd 
gecontinueerd tot het einde van de revalidatie. Tijdens de revalidatie periode was er 
geen statistisch significant verschil tussen beide groepen met betrekking tot de 
verbetering van het ademspierduurvermogen en inspanningsduurvermogen. Kwaliteit 
ven leven en dyspnoe tijdens activiteiten van het dagelijks leven verbeterden ook, 
statistisch en klinisch relevant, in gelijke mate. Echter, ten gevolge van de 5 weken 
RMET in de thuissituatie voorafgaand aan de revalidatie, bereikten patiënten in de 
RMET-groep significant betere toename tijdens de gehele trainingsperiode 
(ademspiertraining thuis en daarop volgende longrevalidatie) in vergelijking met de 
controle-groep ten aanzien van de volgende variabelen: ademspierduurvermogen, 
p<0,001; inspanningsduurvermogen, p=0,03; en dyspnoe sensatie (Borg-score), 
p=0,01. Derhalve luidt de conclusie dat RMET door middel van tube-breathing leidt 
tot een beter resultaat van een longrevalidatie programma met betrekking tot 
ademspierfunctie en inspanningsduurvermogen en een afname van dyspnoe bij 
patiënten met matig en ernstig COPD. 
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DISCUSSIE 
Ademspiertraining wordt sinds enkele decennia toegepast, met als doel verbetering 
van ademspierfunctie en inspanningsvermogen. Deze ademspiertraining werd 
meestal verricht door middel van inspiratoire weerstands-training en threshold 
loading. Deze beide trainingsmethodieken zijn met name gebaseerd op de 
fysiologische principes van krachttraining. Inspiratoire manoeuvres tegen een 
bepaalde weerstand worden gedaan in een lage frequentie en met een hoge kracht. 
De studies waarin ademspier-kracht-training werd toegepast, toonden een 
verbetering van de ademspierfunctie. Echter de resultaten met betrekking tot 
inspanningscapaciteit waren niet altijd even eenduidig. Dit is gedeeltelijk toe te 
schrijven aan het feit dat verschillende trainingsschema’s gebruikt werden. Ook 
werden verschillende patiënten groepen geincludeerd. Bovendien pasten 
verschillende studies ademspiertraining toe, tegelijkertijd met algemene 
inspanningstraining. Dit laatste is een belangrijk onderdeel van een longrevalidatie 
programma. Al met al leidden deze observaties tot de aanbeveling dat 
ademspiertraining toegepast kan worden als een onderdeel van een longrevalidatie 
programma, met name voor patiënten met afgenomen ademspierkracht en 
kortademigheid.1 Literatuur uit de sportgeneeskunde2;3 studies verricht bij gezonde 
vrijwilligers,4;5 patiënten met COPD,6 en cystic fibrose,4 tonen dat ademspiertraining 
die met name gebaseerd is op duurprincipes (in plaats van kracht) een 
veelbelovende vorm van training is, vanwege het feit dat zowel 
ademspierduurvermogen als ook inspanningsduurvermogen verbeteren. Deze vorm 
van ademspierduurtraining is gebaseerd op ademen zonder weerstand met een hoge 
frequentie en met grote teugvolumes: normocapnische hyperpnoe. Vanuit 
fysiologisch oogpunt gezien is deze vorm van training veel meer gericht op de 
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situatie in het dagelijks leven; deze duur-training is veel specifieker in vergelijking 
met krachttraining. Slechts één studie heeft RMET in de thuissituatie toegepast bij 
patiënten met COPD.7 Een duur en gecompliceerd apparaat werd gebruikt voor 
training in de thuissituatie. Deze studie toonde een verbetering van het 
ademspierduurvermogen, de 6-minuten looptest en de maximale zuurstof opname 
(VO2-peak). Er werd echter geen verschil gevonden in inspanningsduurvermogen en 
dyspnoe tijdens activiteiten van het dagelijks leven, tussen de studiegroep en de 
controle-groep. 
Met bovenstaande gegevens als basis, hebben wij onderzocht of RMET in de 
thuissituatie verricht zou kunnen worden door middel van tube-breathing, hetgeen 
een gemakkelijk toepasbare en goedkope techniek is en dientengevolge voor vele 
patiënten beschikbaar is. We hebben aangetoond dat tube-breathing een veilige en 
eenvoudige methode is om RMET toe te passen. Bovendien toonden onze studies 
een verbetering van ademspierduurvermogen, een verbetering van 
inspanningsduurvermogen en een afname van dyspnoe sensatie tijdens inspanning 
ten gevolge van RMET. Voorts nam de dyspnoe tijdens activiteiten van het dagelijks 
leven af en verbeterde de kwaliteit van leven. De effecten van training en 
optimalisatie van de ademhalingsspieren door middel van RMET via tube-breathing 
voorafgaand aan een long revalidatieprogramma werden ook geëvalueerd. Zowel 
inspanningsduurvermogen alsook ademspierduurvermogen toonden een significante 
grotere toename gedurende deze periode in de RMET groep, in vergelijking met de 
controle groep. De perceptie van dyspnoe nam significant sterker af in de RMET 
groep in vergelijking met de controle groep. Er werd overigens geen verschil 
gevonden met betrekking tot dyspnoe en kwaliteit van leven. 
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Chapter 8 
Gezien bovenstaande gegevens kan geconcludeerd worden dat ademhalingsspieren 
op meerdere manieren getraind kunnen worden. Zowel kracht-training, alsook duur-
training zijn in dit kader onderzocht. Echter duur-training heeft slechts een beperkte 
interesse gewekt, met name ten aanzien van het gebruik in de dagelijkse praktijk. Dit 
was mede het gevolg van praktische problemen in de zin van dure en 
gecompliceerde apparatuur, welke nodig was om deze vorm van training uit te 
kunnen voeren. Dit heeft geleid tot een afname van de interesse voor deze techniek 
en dientengevolge weinig klinische studies. Daarentegen werden threshold loaders 
en incentive spirometers ontwikkeld voor kracht-training en door de commerciële 
industrie op de markt gebracht. Sindsdien zijn vele studies met deze apparaten 
verricht en worden zij veelvuldig gebruikt in de dagelijkse praktijk. Echter wanneer we 
kijken naar de situatie in het dagelijkse leven en naar de specificiteit van de training 
dan sluit ademspier-duur-training hier veel beter bij aan. De resultaten van deze 
techniek zijn veelbelovend en met eenvoudige en goedkope uitrusting (± €35,-) welke 
training in de thuissituatie mogelijk maakt kunnen nieuwe studies verricht worden en 
kan routinematig klinisch gebruik van deze techniek geïmplementeerd worden. 
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bedenkingen gehad over de afloop van het project, je hebt dit echter nooit laten 
blijken en altijd een positieve houding aangenomen. Voorts waardeer ik je interesse 
in mijn leven naast het onderzoek! 
 155
 - Dr. Vos, beste Petra, jouw kritische blik en positieve instelling waren (en zijn nog 
steeds) altijd zeer welkom. Onze samenwerking heb ik altijd als buitengewoon 
plezierig ervaren. 
- Dr. Festen, beste Jan, dank voor de inspanningen die je verricht hebt om het 
onderzoek in te passen in het laatste jaar van mijn opleiding.  
- Machteld Jongmans. Ook ik heb mogen profiteren van jouw organisatorische 
kwaliteiten. Dank voor de samenwerking. 
- Afdeling Longfunctie Dekkerswald. Andre, Ger, Kees, Agnes, Petra, Oda, Christel, 
Thea, Irma, Vicky; Dank voor jullie hulp bij de planning en de metingen. Ik heb met 
veel plezier op jullie afdeling gewerkt. 
- Afdeling Longrevalidatie Dekkerswald. Het is goed toeven op een afdeling met een 
prima sfeer. Met veel plezier heb ik mijn onderzoek op jullie afdeling uitgevoerd. 
- Dr. Boot, lieve Cecile, dank voor alles!!! 
- Friese maatschap Longziekten, beste maten, werken vanuit een goede organisatie 
en een plezierige sfeer geeft ruimte voor persoonlijke ontplooiing.  
- Mijn ouders, lieve pap en mam, dank voor jullie interesse, vertrouwen en 
onvoorwaardelijke steun. Hopelijk kan ik nog lang van jullie wijsheden gebruik 
maken. 
- Gijs en Pien, ik vind het prachtig om mijn leven nogmaals te (be-) leven. 
- Helene, samen met jou is alles veel leuker. 
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